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1. Introduction 
1.1. Protein folding problem 
Proteins are the most versatile and complex biomolecules, playing an active role in the 
vast majority of biological processes. Although around 20 % of eukaryotic proteins remain 
intrinsically disordered in vivo (Dunker et al. 2008), a great number of proteins need to 
adopt a proper three-dimensional structure, which is critical for their physiological 
function. In the 1960s, Chris Anfinsen, the pioneer of protein folding, postulated that the 
native three-dimensional structure of a protein is a thermodynamically stable structure, 
determined only by the amino acid sequence and the solution conditions (Anfinsen 1973). 
Nevertheless, the process of obtaining the native structure by a protein is very complex. 
Although it has been extensively studied, it still remains one of the most crucial biological 
problems. 
An unfolded polypeptide chain has an enormously high number of degrees of 
freedom. According to the Cyrus Levinthal paradox, there are too many available 
conformations in the conformational space for an unfolded protein to find the native 
conformation by a random search and in a biologically relevant timescale (Levinthal 
1969). Thus, proteins could not randomly explore all possible conformational states. They 
fold on a funnel-shaped free-energy ‘landscape’, obtaining the native structure by reaching 
the global free energy minimum (Bryngelson et al. 1995; Wolynes 2005). During this 
process, multiple transient states based on local interactions within a polypeptide chain are 
formed and promote the acquisition of the native state. These interactions include mostly 
hydrophobic forces, hydrogen bonds and for certain proteins also ion-pairing (Onuchic and 
Wolynes 2004). Free-energy landscapes are unique for every protein under particular 
conditions and are defined by both thermodynamic and kinetic properties of the 
polypeptide chain. 
An unfolded protein retains high entropy and can populate a large ensemble of 
conformations; therefore it can usually follow several folding pathways down the energy 
funnel to obtain the final conformation (Radford et al. 1992). For the small single-domain 
proteins of up to 100 amino acids, the folding landscapes are usually smooth (Fig. 1.1a), 
allowing very rapid, often two-state transition from the ensemble of unfolded states to the 
final native conformation (Fersht 2000; Onuchic and Wolynes 2004). In the case of larger 
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proteins, comprising around 90 % of all cellular proteins, the folding landscapes are much 
more rugged, leading to the formation of folding intermediates (Brockwell and Radford 
2007) (Fig. 1.1b). Such intermediate states are based on native and non-native interactions 
and can represent partially folded on- or off-pathway steps in the folding process. The on-
pathway intermediates proceed eventually towards the native conformation, whereas the 
off-pathway intermediates are usually kinetically stable and may have to overcome a high 
free-energy barrier to break the non-native interactions and finally acquire the native fold 
(Jahn and Radford 2005; Gianni et al. 2007; Baldwin 2008). Thus, the formation of 
intermediate states can either promote folding or kinetically trap the protein in a metastable 
form, hindering the folding process.  
 
a b 
        
 
Figure 1.1. Smooth and rough energy folding landscapes – a schematic view.  
A polypeptide chain occupies in its denatured state a broad ensemble of structures. During the folding 
process, the polypeptide chain is funneled to the native state either directly, in the case of a smooth 
energy landscape (a), or it requires navigation, possibly via intermediate states, in the case of a rough 
energy landscape (b). 
 
Misfolded or partially folded conformers, especially those kinetically stable, often 
have a tendency to aggregate (Stefani and Dobson 2003; Wright et al. 2005). Aggregation 
is largely driven by the hydrophobic intermolecular interactions and such folding 
intermediates usually expose their hydrophobic residues that should be buried inside the 
native structure. This leads to the association of the molecules in either amorphous 
heterogeneous structures, or, in contrast, in the highly ordered stable fibrils, known as 
amyloids (Eichner et al. 2011). In vivo, the formation of aggregates is usually highly toxic 
for the cells and may lead to deleterious disorders (Chiti and Dobson 2006). Therefore, 
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several mechanisms assisting protein folding, preventing protein aggregation and dealing 
with the already formed aggregates exist in the cell and are necessary for normal cell 
functioning. 
 
1.2. Molecular chaperones 
1.2.1. Role of molecular chaperones 
In vitro, the process of protein folding might take microseconds, for some small 
proteins (Kubelka et al. 2004), or minutes or even hours, for the large, multidomain 
proteins (Herbst et al. 1997). Many proteins fail to fold in vitro under the conditions tested. 
Under in vivo conditions, protein folding is far more difficult, due to the high density of the 
cellular environment, where the protein concentration reaches 300–400 g/l (Zimmerman 
and Trach 1991). Such molecular crowding enhances the chances of intramolecular 
interactions, including those of partially folded and misfolded proteins causing deleterious 
aggregation. Therefore, a versatile network of molecular chaperones, together with co-
chaperones that regulate chaperone activity and substrate specificity, has been developed 
within the cell. Molecular chaperones are defined as proteins that interact with, stabilize or 
assist other protein in acquiring native conformation, not being a part of the protein’s final 
structure (Hartl 1996). Molecular chaperones fulfill inter alia a multitude of protein 
folding-related functions. Firstly, they assist de novo folding of the proteins, so that the 
folding is accomplished on a biologically relevant timescale. During protein synthesis they 
bind and escort the nascent polypeptide chain before it gets completely released from the 
ribosome (Frydman 2001; Kaiser et al. 2006). After protein synthesis is completed, 
molecular chaperones facilitate the folding of nascent proteins. They can passively prevent 
protein aggregation, by shielding the hydrophobic regions of unfolded and partially folded 
proteins (holdases) (Ganea 2001; Hoffmann et al. 2004; Apetri and Horwich 2008) but also 
actively force the folding of the polypeptide chain (foldases), preventing the formation of 
off-pathway intermediates (Langer et al. 1992; Tang et al. 2006; Sharma et al. 2011). 
Secondly, molecular chaperones play a crucial role in repair mechanisms, actively 
dissolving protein aggregates and refolding misfolded species (Goloubinoff et al. 1999; 
Mogk et al. 1999; Liberek et al. 2008; Iosefson et al. 2012). They help mutated proteins to 
obtain a stable structure, providing a buffer system that is critical for the evolution of new 
protein functions (Rutherford and Lindquist 1998; Maisnier-Patin et al. 2005). Thirdly, 
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molecular chaperones are involved in several proteolytic pathways. They facilitate the 
clearance of aggregated and misfolded protein species that are resistant to the repair 
mechanisms, and regulate the normal level of protein turnover (Kriegenburg et al.; Wagner 
et al. 1994; Rottgers et al. 2002). All these functions are absolutely crucial for protein 
quality control and the maintenance of protein homeostasis (proteostasis). Thus, defects in 
the correct functioning of the molecular chaperone network result in detrimental 
consequences at the cellular as well as systemic level.  
 
1.2.2. Classes of molecular chaperones 
Molecular chaperones are grouped in numerous, structurally and mechanistically 
unrelated chaperone classes. The vast majority of chaperones are known as heat-shock 
proteins (Hsps), since they are strongly up-regulated under cellular stress conditions, when 
the amount of misfolded and aggregated proteins is dramatically increased (Schlesinger 
1990). Heat-shock proteins are classified according to their molecular weight: Hsp60 and 
the chaperone Hsp10, Hsp70 and the co-chaperone Hsp40, Hsp90, Hsp100 and the small 
Hsps. 
In bacteria, the first chaperone interacting with the nascent polypeptide chain 
emerging from the ribosome is the trigger factor (Ferbitz et al. 2004). The trigger factor 
does not belong to any of the heat-shock protein classes. The trigger factor interacts 
strongly with the hydrophobic regions of the nascent chain and it gets released upon burial 
of the hydrophobic residues inside the folding protein (Baram et al. 2005; Schlunzen et al. 
2005; Merz et al. 2008). The release of the trigger factor might facilitate further folding or 
a transfer of the protein to the downstream chaperone systems such as DnaK (Teter et al. 
1999; Agashe et al. 2004). In eukaryotes, the role of the Trigger factor is taken over by two 
chaperone complexes called RAC, the Ribosome-Associated Complex (Gautschi et al. 
2001; Otto et al. 2005) and NAC, the Nascent chain-Associated Complex (Wiedmann et al. 
1994; Gautschi et al. 2002).   
The Hsp70 chaperone class is one of the biggest and most versatile chaperone families 
and it is comprised of both constitutively expressed as well as stress-inducible proteins. In 
eukaryotes, Hsp70 chaperones are present in various cellular compartments, including the 
cytosol, nucleus, ER, mitochondria and chloroplasts, and many of those chaperones are 
essential for the cell viability. The Hsp70 chaperones interact with the substrate proteins in 
an ATP-dependent cycle of binding and release (Szabo et al. 1994; Laufen et al. 1999; 
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Mayer et al. 2001; Mayer and Bukau 2005; Jiang et al. 2007). Hsp70 chaperones work as 
primary folding assistants for the newly synthesized polypeptides. This is the case for the 
best characterised representative of the Hsp70 chaperone class, bacterial DnaK, which is 
the main folding helper for nascent bacterial proteins (Bukau and Horwich 1998). 
Substrates that fail to obtain the final structure with the help of Hsp70 cycling may be 
transferred to the chaperonin (Hsp60) system for further folding assistance (Langer et al. 
1992). Apart from functioning in de novo folding, Hsp70 proteins are involved in a number 
of other processes, like protein transport across the organellar membranes (Kang et al. 
1990), disassembly of huge oligomeric protein complexes (Schlossman et al. 1984; 
Rothnie et al. 2011) and degradation of terminally misfolded proteins (Kriegenburg et al.; 
Voos 2009). Hsp70 chaperones are able to fulfill all those various functions due to (i) the 
high number of general as well as specialized members of this chaperone class (Hageman 
et al. 2011); (ii) the co-chaperones that determine substrate specificity and are selectively 
employed by Hsp70 chaperones depending on the cellular process (Silver and Way 1993; 
Kampinga and Craig 2010) and (iii) the cross-talk with the other chaperone systems like 
Hsp60, Hsp90 and Hsp100 (Bukau et al. 2006; Hartl et al. 2011). 
The second main class of molecular chaperones is formed by chaperonins. 
Chaperonins are 0.8–0.9 MDa cage-forming complexes that encapsulate substrate proteins 
in an ATP-dependent fashion for folding inside their cavity (Kerner et al. 2005; Yebenes et 
al. 2011). Chaperonins can be divided into two groups (Horwich et al. 2007). Group I 
chaperonins, known as Hsp60s, are present in bacteria, mitochondria and chloroplasts. 
They consist of heptameric rings and work together with the heptameric Hsp10 proteins 
that form the lid for the folding cage (Braig et al. 1994). The best studied representative of 
this group is the bacterial GroEL, with GroES as an Hsp10 lid (Langer et al. 1992). Group 
II chaperonins are present in archaea (thermosome) and in eukaryotes (TRiC/CCT). They 
are comprised of octa- or nonameric rings and are independent of Hsp10, since their lid is 
formed by -helical extensions of the chaperonin ring (Douglas et al. 2011; Munoz et al. 
2011). Substrates of the chaperonins are usually proteins with highly frustrated folding 
landscapes and which tend to form kinetically trapped aggregation-prone intermediates 
such as actin and tubulin (Horwich and Fenton 2009; Munoz et al. 2011). Encapsulation by 
chaperonins lowers the effective concentration of aggregation-prone species, passively 
preventing aggregation, a mechanism known as ‘kinetic partitioning’ (Apetri and Horwich 
2008). In some cases encapsulation can, however, actively accelerate the folding rates via 
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destabilizing misfolded states and promote the formation of native conformations (Brinker 
et al. 2001; Lin et al. 2008).  
Hsp90 chaperones represent another chaperone class, acting downstream from the 
Hsp70 system. They cooperate with a plethora of co-factors that regulate Hsp90 activity 
and provide substrate specificity and crosstalk with other chaperone systems (Scheufler et 
al. 2000; Zhao and Houry 2007). Similarly to Hsp70 proteins and chaperonins, Hsp90 
undergoes an ATP-dependent cycle in which it interacts with client proteins (Shiau et al. 
2006); however, the exact function and the mechanism of action of this chaperone are not 
well-understood. Various types of Hsp90 clients include transcription factors, such as p53, 
and signal-transduction molecules, such as steroid receptors and kinases (Wandinger et al. 
2008). Thus, the Hsp90 system is involved in a number of crucial cellular processes, such 
as secretory pathways, cellular transport, cell-cycle progression and apoptosis (McClellan 
et al. 2007). Due to its role in cancer development, Hsp90 serves as a potential target for 
anticancer therapy (Neckers 2007; Workman et al. 2007). On the other hand, Hsp90 
functions in buffering the effects of mutations that destabilize proteins, thereby allowing 
the evolution of new protein functions and traits (Rutherford and Lindquist 1998). 
Hsp100 chaperones are members of the large AAA+ ATPase superfamily. These 
chaperones are able to unfold stably folded proteins or even dissociate large aggregates of 
misfolded proteins (Lee et al. 2003; Martin et al. 2005). They consist of one (class II) or 
two (class I) hexameric rings forming a polypeptide translocation channel. In an ATP-
dependent manner, loose regions of the folded/misfolded protein are pulled through that 
channel, thereby unraveling the rest of the protein. A protein unfolded in this way is either 
subjected to a refolding process catalyzed by other chaperone systems, or directed to 
degradation by a protease (P) that is in many cases coupled to the Hsp100 chaperone 
(ClpAP, ClpXP) (Burton and Baker 2005; Inobe and Matouschek 2008). The ClpB/Hsp104 
subfamily of Hsp100 class I chaperones forms unique coiled-coil propeller domains, which 
are crucial for protein recovery from the large aggregates (Lee et al. 2003). Hsp100 
chaperones play a key role in protein quality control, in proteolytic pathways as well as 
under stress conditions (Schmitt et al. 1996; Lee et al. 2001; Weibezahn et al. 2005). 
The small Hsps comprise a large and poorly conserved family of proteins that build 
shell-like complexes of 0.2–0.8 MDa and consist of 12–24 small subunits. Small Hsps 
share a conserved region called -crystallin domain that is involved in subunit interactions 
(Ganea 2001). The expression of these chaperones, or their transition toward the active 
state is, in the most cases, induced upon different types of stress (Kappe et al. 2003). Small 
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Hsp chaperones act by passive stabilization of stress-denatured proteins, thereby 
preventing them from aggregation (Haslbeck et al. 2005). They are involved inter alia in 
the inflammatory response, in the protection against oxidative stress and aging, in anti-
apoptotic processes, as well as in the neuroprotection (Latchman 2002; Hsu et al. 2003; 
Haslbeck et al. 2005). 
Elements of the chaperone machinery, despite its diverse mechanisms, pathways and 
specificity, form complex cellular networks and cooperate with each other in a highly 
regulated manner. This complicated and dynamic functional interplay is, to date, only 
poorly understood and may vary to a great extend in different cell types and depending on 
environmental conditions. 
 
1.3. Mechanism of Hsp70 chaperone system 
The mechanism of action of the Hsp70 chaperones is determined by their structure, 
which is generally well conserved through all species. The Hsp70 chaperones are 
composed of an N-terminal ATPase domain of 45 kDa, which binds nucleotides and 
hydrolyses ATP and a C-terminal 25 kDa peptide binding domain (PBD), which consists 
of -sandwich and -helical lid subdomain and transiently interacts with the substrate 
proteins (Flaherty et al. 1990; Zhu et al. 1996; Liu and Hendrickson 2007; Chang et al. 
2008). The domains are connected via a highly conserved hydrophobic interdomain linker 
that is crucial for interdomain communication and thus for the correct functioning of the 
Hsp70 protein (Han and Christen 2003; Jiang et al. 2005; Vogel et al. 2006; Swain et al. 
2007) (Fig. 1.2). 
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Figure 1.2. Structure of the bacterial Hps70 
chaperone, DnaK, from the wild-type E. coli K-12  
The ATPase domain is shown in magenta, PBD shown in orange 
and the interdomain linker shown in blue using the stick 
representation. Structure view was generated using PyMOL 
program. Protein Data Bank accession code 2KHO (Bertelsen et 
al. 2009). 
 
 
 
The mechanism of Hsp70 action is based on an ATP-dependent cycle of binding and 
release of the extended segments of unfolded proteins that usually consist of five to seven 
hydrophobic residues (Rudiger et al. 1997). It depends on the cooperation of the ATPase 
domain with the PBD. In the ATP-bound state of the ATPase domain, the PBD remains in 
an open conformation leading to the high on- and off-rates of substrate binding. Upon ATP 
hydrolysis, the PBD closes, which causes an increase in the affinity to the substrate and 
prevents its dissociation. Exchange of ADP for the new ATP molecule enables opening of 
the PBD and release of the substrate, completing the ATP-driven reaction cycle (Fig. 1.3). 
Thus, the nucleotide state of the ATPase domain determines the substrate affinity of the 
PBD. On the other hand, the substrate binding to the PBD stimulates ATP hydrolysis by 
the ATPase domain (Szabo et al. 1994; Buchberger et al. 1995; McCarty et al. 1995; Woo 
et al. 2009). This constant coupling of the conformational changes in both domains is 
mediated by the interdomain linker, which binds to the hydrophobic cleft in ATPase 
domain and is alone able to stimulate its activity (Vogel et al. 2006; Swain et al. 2007). 
As the basal ATPase activity of Hsp70 proteins is relatively low (0.018–1 min-1), and 
the substrate stimulation ranges only between 2 to 10-fold (Mayer et al. 2000; Mayer et al. 
2000), Hsp70 proteins require two types of co-chaperones that accelerate the ATPase 
cycle: the J domain-containing proteins, classified also as Hsp40s and the nucleotide 
exchange factors (Liberek et al. 1991; Rungeling et al. 1999) (Fig. 1.3). The J domain-
containing proteins (J proteins) stimulate the ATP hydrolysis of Hsp70 up to 1000-fold 
(Cyr et al. 1994; Karzai and McMacken 1996; Laufen et al. 1999). Additionally, they may 
themselves recognize and bind substrate proteins and target them to the Hsp70 chaperone, 
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thereby determining substrate specificity (Han and Christen 2003; Summers et al. 2009; 
Kampinga and Craig 2010). The nucleotide exchange factors interact with the ATPase 
domain of Hsp70 proteins and trigger opening of the nucleotide-binding cleft, facilitating 
ADP release and thus re-binding of new ATP molecule (Schonfeld et al. 1995; Skowyra 
and Wickner 1995; Brehmer et al. 2004). Thus, nucleotide exchange factors control the 
lifetime of the Hsp70-substrate complex. 
 
 
 
 
Figure 1.3. ATPase cycle of an Hsp70 chaperone  
(1) Unfolded substrate binds weakly to the Hsp70 in an ATP-bound (open) state. (2) ATP hydrolysis 
stimulated by a J protein leads to Hsp70 lid closure and substrate entrapment. (3) Nucleotide exchange 
factor (NEF) facilitates ADP release. (4) New ATP binds and triggers lid opening and subsequent 
substrate release. 
 
 
1.4. Role of the mitochondrial chaperones in the biogenesis  
of mitochondria 
As one of the most crucial cellular compartments, mitochondria, the endosymbiontic 
organelles, play an indispensable role for the cell functioning. Apart from energy 
production and biosynthesis of essential metabolites, mitochondria are involved in a 
number of cellular pathways and processes like signaling, cell cycle, stress response and 
apoptosis. Thus, a large set of proteins resides in this organelle, including important 
enzyme complexes, proteins responsible for the mitochondrial morphology, as well as a 
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variety of molecular chaperones that regulate and maintain the correct protein level, 
activity and turnover (Voos and Rottgers 2002; Voos 2009). 
The molecular chaperones play an indispensable function in the biogenesis of the 
mitochondrial proteins. They are involved in the complicated process of protein import 
into the mitochondria, together with a myriad of other factors. Moreover, since the 
mitochondrial proteins are translocated in an unfolded manner, they need to fold de novo 
upon reaching the final destination. Molecular chaperones assist in the folding process of 
those proteins and of mitochondrially encoded proteins, and help many of them to 
assemble into functional complexes. 
 
1.4.1. Mitochondrial import pathways 
Being highly integrated into the metabolism of the host cell, mitochondria have 
transferred the vast majority of their genes into the nuclear genome. Therefore, apart from 
a few proteins still encoded in the mitochondrial chromosome, mitochondrial proteins are 
synthesized on the cytoplasmic ribosomes as precursor proteins and subsequently 
translocated into the correct mitochondrial subcompartment: the outer mitochondrial 
membrane, the inner membrane divided into the cristae membrane and the inner boundary 
membrane, the intermembrane space (IMS) and the innermost matrix. 
Mitochondrial protein transport is carried out by the large protein complexes spanning 
the mitochondrial membranes called translocases (Endo et al. 2003; Koehler 2004; Rehling 
et al. 2004; Neupert and Herrmann 2007). Virtually all mitochondrial precursor proteins 
enter the mitochondria through the TOM complex (the translocase of outer membrane), 
consisting of receptor proteins recognizing the mitochondrial precursors and a protein-
conducting channel (Ahting et al. 1999; Rapaport 2005; Perry et al. 2008). The TOM 
complex is sufficient for the import of many outer membrane and IMS proteins. Some 
outer membrane proteins require assistance of the soluble small TIM complexes 
(translocase of the inner membrane) and enter the outer membrane via the TOB/SAM 
complex (topogenesis of outer membrane-barrel proteins/sorting and assembly 
machinery) (Kozjak et al. 2003; Wiedemann et al. 2004; Paschen et al. 2005; Endo and 
Yamano 2010). The small cysteine-containing intermembrane space proteins use the 
disulfide relay system of Mia40-Erv1 that oxidatively folds them, thereby trapping them in 
the intermembrane space (Herrmann and Riemer; Hell 2008; Sideris and Tokatlidis 2010). 
The large hydrophobic inner membrane proteins, such as the carrier family members, are 
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escorted by the small TIM complexes to the TIM22 translocase that inserts them into the 
inner membrane (Sirrenberg et al. 1996; Bauer et al. 2000; Rehling et al. 2003).  
After entering the mitochondria through the TOM pore, the great majority of 
mitochondrial proteins are imported further via the so-called general import pathway, 
passing through the TIM23 translocase (Marom et al. 2010; Mokranjac and Neupert 2010; 
van der Laan et al. 2010). Those proteins are directed either into the mitochondrial matrix 
or into the inner membrane and usually contain a cleavable mitochondrial targeting 
sequence located in most cases at the N terminus. Their translocation is driven by the ATP-
hydrolysis by the mitochondrial Hsp70. The inner membrane proteins are either laterally 
released from the TIM23 complex via the stop-transfer mechanism or are first completely 
imported into the matrix and then inserted into the membrane with the assistance of OXA1 
complex. The OXA1 pathway, known also as a ‘conservative sorting pathway’ due to its 
origin from the bacterial ancestors, is also used by the mitochondrially-encoded proteins 
destined to the inner membrane (Hell et al. 1998; Hell et al. 2001; Ott and Herrmann 
2009). The mitochondrial import machinery and the different mitochondrial import 
pathways are schematically presented in Fig. 1.4. 
 
 
 
Figure 1.4. An overview of pathways of pre-protein import and sorting  
into the mitochondria. OM, outer membrane, IMS, intermembrane space, IM, inner membrane. 
Adapted from (Mokranjac and Neupert 2008). 
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Mitochondrial proteins, due to the size of the translocating channels, are, as mentioned 
above, transported in an unfolded state. Therefore, the imported proteins have to fold 
inside the mitochondria and may require the help of molecular chaperones in that process.  
In the mitochondrial matrix, there are several chaperone systems acting as folding 
assistants. The mitochondrial Hsp70 chaperone system and the Hsp60 chaperonin are the 
main folding helpers of mitochondria (Voos and Rottgers 2002; Voos 2009). Since 
mitochondrial Hsp70 interacts with the precursor proteins being imported into the 
mitochondrial matrix, it is also the first chaperone that mediates folding (Kang et al. 1990; 
Liu et al. 2001). Many mitochondrial proteins are subsequently transferred from 
mitochondrial Hsp70 to the Hsp60 chaperonin where they undergo further folding steps 
inside the chaperonin cavity (Endo 1991; Rospert et al. 1996; Heyrovska et al. 1998). The 
third chaperone system in the mitochondrial matrix, the mitochondrial Hsp78 complex, 
belongs to the Hsp100 chaperone class and is a homologue of the bacterial ClpB chaperone 
(Moczko et al. 1995; Schmitt et al. 1995; Krzewska et al. 2001). The Hsp78 chaperone 
displays mostly disaggregation and refolding activity and is particularly required under 
stress conditions (Schmitt et al. 1996; von Janowsky et al. 2006). 
 
1.4.2. Mitochondrial Hsp70 chaperone systems 
In the mitochondrial matrix of the yeast Saccharomyces cerevisiae there are three 
members of Hsp70 family: Ssc1p, Ssq1p and Ecm10 (Fig. 1.5). The most abundant 
mitochondrial Hsp70, known as mtHsp70 or Ssc1p, is the major mitochondrial folding 
helper that assists in de novo folding and prevents aggregation of newly imported proteins 
(Craig et al. 1989; Kawai et al. 2001; Liu et al. 2001). Additionally, a fraction of Ssc1 is 
associated with the TIM23 translocase and it plays a key role in the general import 
pathway of the mitochondrial precursors (Kang et al. 1990; Manning-Krieg et al. 1991; 
Schneider et al. 1994; Ungermann et al. 1994; Horst et al. 1997; Liu et al. 2003; D'Silva et 
al. 2004). The Ssc1p homologue, Ssq1p is involved in the biogenesis of FeS cluster-
containing proteins that takes place in mitochondria (Lutz et al. 2001; Dutkiewicz et al. 
2003; Dutkiewicz et al. 2004). Although the exact mechanism of Ssq1 is not completely 
understood, it most probably functions in the transfer of the assembled FeS cluster to the 
recipient apoproteins (Dutkiewicz et al. 2006). The third member of the mitochondrial 
Hsp70 subfamily, called Ecm10 or Ssc3p, shares over 82 % sequence identity with Ssc1. 
However, it has been shown not to overlap functionally with Ssc1 due to its decreased 
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stability and differences in interaction with co-chaperones (Pareek et al. 2011). In vivo, 
expression levels of Ecm10 are very low and since no phenotype upon ECM10 gene 
deletion has been observed, the physiological function remains to be determined (Baumann 
et al. 2000). 
Structures of all three mitochondrial Hsp70s resemble the structure of other Hsp70 
proteins. They consists of a highly conserved N-terminal ATPase domain and a less 
conserved PBD built of the -stranded substrate binding pocket and the -helical lid 
(Bukau and Horwich 1998). The domains are connected via an interdomain linker that 
mediates domain crosstalk and consists of four hydrophobic amino acid residues (VLLL) 
(Han and Christen 2003; Jiang et al. 2005; Vogel et al. 2006; Swain et al. 2007). 
All three mitochondrial Hsp70 proteins interact with the co-chaperones regulating 
their activity and specificity. Ssc1 cooperates with two distinct J proteins: Mdj1p in the 
processes of protein folding (Rowley et al. 1994), and Tim14 during the import reaction 
(D'Silva et al. 2003; Mokranjac et al. 2003; Truscott et al. 2003). Ssq1 requires another J 
protein, Jac1, that interacts with the FeS cluster scaffold protein Isu1 (Lutz et al. 2001; 
Voisine et al. 2001). Mitochondrial nucleotide exchange factor Mge1p seems to be shared 
by all three members of mtHsp70 subfamily (Miao et al. 1997; Schmidt et al. 2001; Pareek 
et al. 2011). 
In higher eukaryotes, only one or two isoforms of Hsp70 protein are present in the 
mitochondria (Wadhwa et al. 1993). In human, the only isoform is called mortalin, due to 
its involvement in cell death and tumorigenesis (Wadhwa et al. 1993; Burbulla et al. 2010). 
Mortalin fulfills the functions of both Ssc1 and Ssq1 and was reported to be additionally 
present in other cellular compartments, where it interacts with p53 and proteins of the Ras-
Raf pathways (Kaul et al. 1993; Ran et al. 2000; Wadhwa et al. 2002). However, the 
function and relevance of the extramitochondrially localized mortalin remain unclear to 
date. 
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Figure 1.5. Mitochondrial Hsp70 chaperone systems in S. cerevisiae. See text for 
details. 
 
1.4.3. Role of the mitochondrial Hsp70 chaperone Ssc1 in protein import and 
folding 
Ssc1 plays a critical role for the functioning of mitochondria and is essential for the 
cell viability under all conditions (Craig et al. 1987). It is involved in two independent 
processes underlying the biogenesis of mitochondrial proteins: pre-protein import into 
mitochondria and de novo folding of proteins in the mitochondrial matrix. 
Ssc1 is a main constituent of the import motor of the TIM23 translocase, thereby 
driving protein translocation in the general import pathway. The import motor is associated 
with the core of the TIM23 translocase and consists of Tim44, Ssc1 and the co-chaperones 
Tim14/Pam18, Tim16/Pam16 and Mge1 (Neupert and Brunner 2002; Marom et al. 2010; 
van der Laan et al. 2010). Tim44 plays a role as an adapter protein and it docks Ssc1 onto 
the membrane (Kronidou et al. 1994; Rassow et al. 1994; Schneider et al. 1994). Ssc1 is 
the only ATP-consuming unit of the import motor. The cycles of ATP hydrolysis by Ssc1 
are coupled to the vectorial translocation of the polypeptide chain into the mitochondrial 
matrix. The hydrolysis rates are stimulated by Tim14 which is a J protein and by the 
nucleotide exchange factor Mge1 (Laloraya et al. 1994; Nakai et al. 1994; Westermann et 
al. 1995; Deloche and Georgopoulos 1996; D'Silva et al. 2003; Mokranjac et al. 2003; 
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Truscott et al. 2003). In the absence of incoming pre-protein, the stimulatory function of 
Tim14 is inhibited by Tim16 associated with it (Frazier et al. 2004; Kozany et al. 2004; Li 
et al. 2004; Mokranjac et al. 2006). 
The suggested mechanism of translocation is called a trapping mechanism and is 
based on the Brownian motion of the pre-protein in transit (Ungermann et al. 1994; 
Neupert and Brunner 2002; Okamoto et al. 2002; Liu et al. 2003; Yamano et al. 2008; 
Marom et al. 2010). In the first step of translocation, the membrane potential drives 
transport of the positively charged presequence across the inner mitochondrial membrane. 
When the pre-protein emerges from the TIM23 channel on the matrix side, it is recognized 
by Tim44 and transferred to Ssc1. Upon pre-protein binding, Ssc1 dissociates from Tim44, 
allowing for a new Ssc1 molecule to bind. ATP hydrolysis stimulated by Tim14 leads to 
entrapment of pre-protein by the PBD of Ssc1 and prevents the pre-protein from 
backsliding. Via Brownian motion, a part of pre-protein remaining outside of mitochondria 
gradually unfolds and moves deeper into the matrix. There, it gets bound by another Ssc1 
molecule associated with Tim44, and the cycle repeats. Mge1 helps Ssc1 to exchange ADP 
to ATP which causes the release of pre-protein and allows Ssc1 to bind to Tim44 again. In 
the end, the cycling of Ssc1 leads to the complete unidirectional translocation of the pre-
protein into the mitochondrial matrix in a hand-over-hand manner 
An alternative model of the pre-protein translocation, called the power stroke model, 
was also suggested (Glick 1995; Voos et al. 1996; Horst et al. 1997; Matouschek et al. 
1997; Voisine et al. 1999; Krayl et al. 2007). It this model, the ATP hydrolysis by Ssc1 
triggers its conformational change that leads to an active pulling of the pre-protein into the 
mitochondrial matrix. That causes a global unfolding of the pre-protein remaining on the 
cytosolic side and drives the translocation process. It is likely that both mechanisms are 
used for the pre-protein translocation, depending on the pre-protein itself and its state of 
folding outside of the mitochondria (van der Laan et al. 2010).  
Apart from the function in the import of pre-proteins, Ssc1 is also one of the main 
folding helpers of mitochondria (Kang et al. 1990; Liu et al. 2001). Ssc1 interacts with 
newly imported, unfolded proteins, prevents their aggregation and assists in folding. 
Moreover, it helps in the folding of mitochondrially encoded proteins and their assembly 
into macromolecular complexes (Herrmann et al. 1994). In addition, Ssc1 cooperates with 
the Hsp78 chaperone on refolding and reactivation of misfolded and aggregated proteins 
(Krzewska et al. 2001). In all these processes, Ssc1 employs a soluble J protein, Mdj1, that 
stimulates the ATP hydrolysis of Ssc1, and, like during the import reactions, nucleotide 
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exchange factor Mge1 (Rowley et al. 1994; Westermann et al. 1996; Miao et al. 1997; 
Schmidt et al. 2001; Pareek et al. 2011). The Mdj1 protein, specific for the protein folding 
action of Ssc1, also shows a chaperone activity by itself and is involved in inheritance of 
the mitochondrial genome (Prip-Buus et al. 1996; Duchniewicz et al. 1999). The role of the 
Ssc1 chaperone system in protein folding was demonstrated both in vivo and in a 
reconstituted system using model substrates, such as Su9-DHFR and luciferase (Kang et al. 
1990; Manning-Krieg et al. 1991; Rospert et al. 1996; Liu et al. 2001). 
 
1.4.4. Hep1 – a chaperone for a chaperone 
Although Ssc1 prevents protein aggregation and is involved in dissociation of already 
aggregated proteins, it has itself the propensity to aggregate. Therefore, to be fully active in 
vivo and in vitro, Ssc1 requires the helper protein, the chaperone Hep1 (Sanjuan Szklarz et 
al. 2005; Sichting et al. 2005). 
Hep1, also known as Tim15/Zim17 (Burri et al. 2004; Yamamoto et al. 2005), was 
identified in Saccharomyces cerevisiae as an ATP-dependent interaction partner of Ssc1 
(Sichting et al. 2005). Hep1 is a small 17 kDa protein, which binds zinc ions (Burri et al. 
2004; Sichting et al. 2005; Yamamoto et al. 2005). It is present throughout the eukaryotic 
kingdom, however only in mitochondria and chloroplasts. To date, no bacterial Hep1 
counterpart was found. 
Deletion of the HEP1 gene in S. cerevisiae causes a pleiotropic phenotype, including a 
temperature-sensitive growth defect, impairment of the pre-protein import into the 
mitochondria via the general import pathway, decreased activity of FeS cluster-containing 
proteins, mitochondrial and nuclear genome instability and altered mitochondrial 
morphology (Burri et al. 2004; Sanjuan Szklarz et al. 2005; Sichting et al. 2005; 
Yamamoto et al. 2005; Diaz de la Loza et al. 2011). All those defects could be explained 
by the impaired activity of the mitochondrial Hsp70 proteins. Indeed, in the absence of 
Hep1, Ssc1 and Ssq1 were found to be aggregated and partially non-functional (Sanjuan 
Szklarz et al. 2005; Sichting et al. 2005). Therefore, Hep stands for Hsp70 escort protein, 
as it prevents aggregation and keeps mitochondrial Hsp70s in a functional state. The 
importance of Hep1 for Ssc1 was additionally shown in the bacterial system. Only upon 
co-expression with Hep1, Ssc1 was recovered in a soluble form (Sichting et al. 2005). The 
same protective effect was observed towards the human mtHsp70 (HSPA9) and the 
chloroplast HSP70B from the algae Chlamydomonas reinhardtii upon bacterial co-
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expression with the corresponding Hep proteins (Willmund et al. 2008; Zhai et al. 2008). 
Additionally, Hep1 prevented oligomerisation and loss of activity of the purified Ssc1 in 
vitro (Sichting et al. 2005). All these findings suggest that the main function of Hep 
proteins is the maintenance of the structure and function of the cognate Hsp70 chaperones.  
It was also put forward that yeast Hep1 is a constituent of the import motor of TIM23 
translocase, possibly functioning as a ‘fractured’ J protein, that contributes a zinc finger 
domain to the Tim14 in trans (Burri et al. 2004; Yamamoto et al. 2005). As such a 
component, Hep1 would present the incoming substrate to the Ssc1 associated with the 
translocase. However, Hep1 was found not to be associated with the other translocase 
components. Therefore, this hypothesis remains unlikely (Sichting et al. 2005).  
The NMR structure of the core part of Hep1 revealed it to be an L-shaped molecule, 
with two conserved zinc-finger motifs located at one end (Fig. 1.6). Binding of the zinc 
ions seems to be critical for the overall structure of the protein (Momose et al. 2007). 
Although the zinc-finger motifs of Hep1 resemble those of other J proteins, the overall fold 
of Hep1 is different from the cysteine-rich domain of DnaJ, the bacterial representative of J 
proteins (Martinez-Yamout et al. 2000; Momose et al. 2007). On the convex face of the L, 
a large acidic groove is present. The concave face of the L contains an aspartate residue 
(Asp111) and two positively charged residues, Arg106 and His107, in close proximity to 
the zinc-finger motifs. Mutational analysis revealed Asp111, Arg106 and His107 to be 
crucial for the in vivo function of Hep1 and for the interaction with Ssc1 in vitro. This 
suggests that the concave face of Hep1 is the potential binding site for Ssc1 (Momose et al. 
2007). The mechanism of the function of the Hep1 protein as well as the structural 
determinants of Ssc1, critical for the interaction with Hep1, are, however, still unclear.  
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Figure 1.6. Structure of Hep1 core from S. cerevisiae  
Amino acid residues important for the Hep1 function are indicated. The zinc ion is shown as a red 
sphere. Structure view generated using PyMOL program. Protein Data Bank accession code 2E2Z 
(Momose et al. 2007). 
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1.5. Aim of the present study 
The yeast mitochondrial Hsp70 chaperone Ssc1 is a crucial component of the 
mitochondrial chaperone network, essential for the function of mitochondria and, 
therefore, for the survival of the cell. Despite being involved in protein folding and 
prevention of protein aggregation, Ssc1 itself has propensity to aggregate. Thus, a helper 
protein, the chaperone Hep1 is required to maintain the structure and function of the Ssc1 
chaperone. Why a chaperone has the propensity to aggregate and how Hep1 prevents the 
aggregation process, remained unclear. To get insight into the mechanism and function of 
Hep1 in the prevention of aggregation of Ssc1, it was the first aim of this study to analyse 
the structural determinants of Ssc1 for the propensity to aggregate and for the interaction 
with Hep1. 
Based on the phenotypes observed in the absence of Hep1, one could expect Hep1 to 
be involved in the de novo folding of Ssc1. The biogenesis of molecular chaperones, in 
particular the Hsp70 chaperones, including their folding de novo, has been poorly studied. 
The second aim of the present study was to characterise the de novo folding of the Ssc1 
chaperone and to elucidate a potential chaperone function of Hep1 in this process, 
establishing and employing both in organello and in vivo approaches. In addition, the 
folding process should be reconstituted with purified components, to provide more insights 
into the folding process of Ssc1 on the molecular level. 
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2. Materials and methods 
2.1. Molecular biology methods 
2.1.1. Isolation of plasmid DNA from E.coli 
Plasmid DNA from E. coli cells was isolated using the PureYield Plasmid Midiprep 
System kit (Promega). Bacteria carrying the plasmid of interest were inoculated in 40–50 
ml LB-Amp medium and grown overnight (37 ºC with shaking at 140 rpm). Cells were 
harvested by centrifugation (10000 x g, 10 min, RT) and resuspended in 6 ml of Cell 
Resuspension Solution. Next, cells were lysed for 3 min with 6 ml of Cell Lysis Solution 
and neutralized with 10 ml of Neutralization Solution. Precipitated material was removed 
by centrifugation (10000 x g, 10 min, 4ºC), and the supernatant was applied to a clarifying 
column and an anion-exchange column to bind DNA and placed onto a vacuum manifold. 
Next, the anion-exchange column was washed with 5 ml of Endotoxin Removal Wash and 
then with 20 ml of the Column Wash Solution. The column was dried under vacuum for 30 
sec, plasmid DNA was eluted with 600 μl of deionized water and DNA concentration was 
measured by the NanoDrop 2000c (Thermo Scientific). Plasmid DNA was stored at –20 
ºC. 
 
2.1.2. Amplification of DNA sequences by Polymerase Chain Reaction (PCR) 
A PCR reaction was used to amplify DNA fragments used for subsequent cloning. A 
typical mix for the PCR reaction (total volume of 100 ml) contained 1.25 U of GoTaq® 
DNA Polymerase (Promega), 20 l of 5X Green GoTaq® Reaction Buffer (Promega), 2 l 
dNTPs (10 mM each), 1 l of forward and reverse primer (50 M each) and 50–150 ng 
plasmid DNA as a template. The following PCR program, with small variations depending 
on the DNA sequence, was used: 
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Cycle step Temperature Time No. of cycles 
Initial denaturation 94 °C 4 min 1 
Denaturation 94 °C 1 min
30 Primer annealing 60–68 °C 30 sec
Primer extension 72 °C 1– 2.5 min
Final extension 72 °C 10 min 1 
Cooling 4 °C - - 
 
DNA fragments obtained by PCR were analysed by agarose gel electrophoresis (2.1.5). 
 
2.1.3. Restriction digestion of DNA 
DNA was digested with 1 l (2–5 U) of the appropriate restriction endonucleases (New 
England Biolabs) per 1 g of DNA in a buffer specific for the restriction enzyme. 
Reactions were carried out in 37 °C for 1 h in a total volume of 100 l. Digested DNA was 
analysed by agarose gel electrophoresis (2.1.5). 
 
2.1.4. Ligation of DNA fragments 
A DNA fragment and a target vector after digestion with the same or compatible restriction 
enzymes were ligated together using T4 DNA ligase (Promega). 80–200 ng of vector DNA 
and 3–10-fold molar excess of DNA fragment were incubated in ligase buffer with 
addition of 1 U of T4 DNA ligase in a final volume of 10 l. Ligation was carried out at 25 
°C for 1–3 h. 1 l of the ligation mix was transformed into electrocompetent MH1 E. coli 
cells (2.1.8). 
 
Ligase buffer 
30 mM TRIS-HCl pH 7.8,  
10 mM MgCl2,  
10 mM DTT,  
1 mM ATP 
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2.1.5. Agarose gel electrophoresis of DNA 
DNA fragments were separated according to their sizes by horizontal agarose gel 
electrophoresis. Agarose gels were prepared in TAE buffer with addition of 0.5 μg/ml 
ethidium bromide in a pre-casted container. The DNA sample was supplemented with a 10 
x loading buffer and loaded on a 0.8–1.5 % (w/v) agarose gel, depending on the fragment 
size of the DNA. Gels were run in TAE buffer at 90–150 V depending on the gel sizes. 
Separated DNA fragments were visualized under UV light. 
 
TAE buffer 
40 mM TRIS-acetate pH 7.5,  
20 mM Na-acetate,  
1 mM EDTA 
10 x loading buffer 
40 % (v/v) glycerol,  
0.25 % (w/v) bromphenol-blue,  
0.25 % (w/v) xylencyanol 
 
2.1.6. Isolation of DNA fragments from agarose gel 
Selected DNA fragments were cut out from the gel with a scalpel under UV light. DNA 
was extracted from the excised agarose block using the Wizard SV® Gel and PCR Clean-
Up System kit (Promega). One volume of Membrane Binding Solution was added to the 
sample and the sample was incubated at 65 °C until the agarose block completely 
dissolved. Next, the sample was applied to the DNA-binding silica column. After a double 
wash with the Membrane Washing Solution, the column was quickly dried by a short 
centrifugation step. Bound DNA was eluted with 30–50 l of nuclease-free H2O. The 
concentration of the isolated DNA was measured with the NanoDrop 2000c. 
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2.1.7. Overview of E. coli strains used 
Strain Genotype Reference 
MH1 MC1061 derivative; araD139, lacX74, galU, 
galK, hsr, hsm+, strA 
(Casadaban and Cohen 
1980) 
XL1Blue 
supE44, hsdR17, recA1, endA1, gyrA96, thi-1, 
relA1, lac-, F’[proAB+, lacIq, lacZΔM15, 
Tn10(tetr)] 
Commercially available 
from Stratagene 
BL21(DE3) 
F–, ompT, gal, dcm, lon, hsdSB(rB- mB-), 
λ(DE3[lacI lacUV5-T7 gene 1 ind1 sam7 
nin5]) 
Commercially available 
from Novagen 
BL21(DE3) 
DnaK 
F–, ompT, gal, dcm, lon, hsdSB(rB- mB-), 
λ(DE3[lacI lacUV5-T7 gene 1 ind1 sam7 
nin5]) dnaK52::Cmr 
Kind gift from M. 
Mayer and B. Bukau, 
University of Heidelberg
 
2.1.8. Preparation of electrocompetent E. coli cells 
500 ml of LB culture was inoculated with 1 ml of the overnight culture of E. coli cells. The 
culture was grown at 37ºC with shaking at 140 rpm until OD600 = ca. 0.5 and then 
incubated on ice for 30 min. Next, cells were harvested by centrifugation for 5 min at 4400 
x g at 4 °C and resuspended in 500 ml of sterile, ice-cold 10 % (v/v) glycerol. The 
procedure of harvesting and resuspending was repeated with 250 and 50 ml ice-cold 10 % 
(v/v) glycerol. Finally, cell pellet was resuspended in 500 l of ice-cold 10 % (v/v) 
glycerol, cells were aliquoted (40 l per test-tube) and stored at -80 °C. 
 
2.1.9. Transformation of E. coli cells by electroporation 
The ligation mixtures or the plasmid DNA were transformed into electrocompetent E. coli 
cells by electroporation. A 40 l aliquot of electrocompetent cells was thawed on ice and 1 
l of ligation mixture or plasmid DNA (10–50 ng) was added and incubated for 1 min on 
ice. Next, cell suspension was transferred to the 0.2 cm-thick cooled electroporation 
cuvette and the cuvette was placed in the electroporation apparatus ‘Gene Pulser’ 
(BioRad). The apparatus was set to 1.5 kV, 400 Ω, 25 μF, and time constant 8–9 ms and 
the cell suspension was treated with a short electrical pulse. Next, cells were diluted with 1 
ml of ice-cold SOC medium, transferred to a test-tube and incubated with shaking at 37 °C 
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for recovery. Cells were then harvested by short centrifugation, resuspended in 100 l of 
SOC medium and plated on LB plates supplemented with 100 μg/ml ampicillin. Plates 
were incubated at 37 °C overnight. To check whether obtained bacterial colonies contained 
the right construct, 5–20 colonies were tested by PCR. To this end, a little amount of 
bacterial material was used in the reaction instead of template DNA and the procedure was 
performed as described in 2.1.2.  
 
2.1.10. Overview of plasmids used 
Plasmid Description Reference 
pYX142-ATPase-his 
For over-expression of C-terminally 
his-tagged ATPase domain in yeast 
mitochondria 
(Blamowska et al. 
2011) 
pYX142-pSu9-PBD-his 
For over-expression of C-terminally 
his-tagged PBD in yeast 
mitochondria 
(Blamowska et al. 
2011) 
pYX142-Ssc1-his 
For over-expression of C-terminally 
his-tagged Ssc1 in yeast 
mitochondria 
(Blamowska et al. 
2011) 
pYX142-ATPaseLinker-his 
For over-expression of C-terminally 
his-tagged ATPaseLinker in yeast 
mitochondria 
This thesis 
pYX142-ATPaseA4-his 
For over-expression of C-terminally 
his-tagged ATPaseA4 in yeast 
mitochondria 
This thesis 
pYX142-ATPaseLinker 
For over-expression of non-tagged 
ATPaseLinker in yeast mitochondria
This thesis 
pGEM4-Ssc1 
For in vitro transcription and 
translation of Ssc1 
(Moro et al. 2002)
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pGEM4-Cytb2(1-167)DHFR 
Template for cloning of b2(87–167) 
DHFR DNA sequence into pGEM4 
vector 
(Schneider et al. 
1994) 
pGEM4-b2(87–167)DHFR 
Acceptor vector for cloning of single 
Ssc1 domains as fusion proteins into 
pGEM4 vector 
This thesis 
pGEM4-ATPase-b2(87–
167)DHFR 
For in vitro transcription and 
translation of ATPase-DHFR fusion 
protein 
This thesis 
pGEM4-pSu9-PBD-b2(87–
167)DHFR 
For in vitro transcription and 
translation of PBD-DHFR fusion 
protein 
This thesis 
pGEM4-ATPaseLinker-b2(87–
167)DHFR 
For in vitro transcription and 
translation of ATPaseLinker-DHFR 
fusion protein 
This thesis 
pGEM4-ATPaseA4-b2(87–
167)DHFR 
For in vitro transcription and 
translation of ATPaseA4-DHFR 
fusion protein 
This thesis 
pGEM4-Ssc1A4 
For in vitro transcription and 
translation of Ssc1A4 mutant 
This thesis 
pETDuet- 
Ssc1mat+his-Hep1mat 
For co-expression of mature Ssc1 
and N-terminally his-tagged mature 
Hep1 in E. coli 
(Sichting et al. 
2005) 
pETDuet-
ATPaseLinkermat+his-Hep1mat 
For co-expression of mature 
ATPaseLinker and N-terminally his-
tagged mature Hep1 in E. coli 
(Blamowska et al. 
2011) 
pETDuet-PBD-his 
For expression of C-terminally his-
tagged PBD in E. coli 
(Blamowska et al. 
2011) 
pQE30-his-Hep1mat 
For expression of N-terminally his-
tagged mature Hep1 in E. coli 
(Sichting et al. 
2005) 
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pQE30-his-Mge1mat 
For expression of N-terminally his-
tagged mature Mge1 in E. coli 
(Horst et al. 1997)
pETDuet-his-TEV-DnaJ 
For expression of N-terminally his-
tagged DnaJ in E. coli 
Kind gift of D. 
Mokranjac,  
LMU München 
 
2.1.11. Cloning strategies 
Plasmids generated in this thesis were cloned using the following strategies. Sequences of 
the generated constructs were confirmed by sequencing by Eurofins MWG GmbH 
(Ebersberg). 
 
pYX142-ATPaseLinker-his 
The coding sequence for the ATPase domain with the subsequent interdomain linker of 
Ssc1 (amino acid residues 1–415) was amplified by PCR using primers 5´EcoRI-Ssc1 and 
3´Ssc1dC239-his-XhoI and the plasmid pYX142-Ssc1-his as a template. The obtained 
DNA fragment was cloned into the vector pYX142 using EcoRI and XhoI restriction sites 
encoded in the primers. 
5´EcoRI-Ssc1: 
5´- ATAT GAATTC ATG CTT GCT GCT AAA AAC ATA C - 3´ 
3´Ssc1dC239-his-XhoI: 
5´- ATAT CTCGAG TTA ATG GTG ATG GTG ATG GTG TAA TAA TAA GAC GTCAG - 3´ 
 
pYX142-ATPaseA4-his 
The coding sequence for the ATPase domain of Ssc1 (amino acid residues 1–411) with the 
additional four alanine residues was amplified by PCR using primers 5´EcoRI-Ssc1 and 
3´Ssc1dC239-A4-his-XhoI and the plasmid pYX142-Ssc1-his as a template. The obtained 
DNA fragment was cloned into the vector pYX142 using EcoRI and XhoI restriction sites 
encoded in the primers. 
3´Ssc1dC239-A4-his-XhoI: 
5´- ATAT CTCGAG TTA ATG GTG ATG GTG ATG GTG AGC TGC AGC GGC GTC AGT 
AAC CTC - 3´ 
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pYX142-ATPaseLinker 
The coding sequence for the ATPase domain with the subsequent interdomain linker of 
Ssc1 (amino acid residues 1–415) was amplified by PCR using primers 5´EcoRI-Ssc1 and 
3´Ssc1dC239-XhoI and the plasmid pYX142-Ssc1-his as a template. The obtained DNA 
fragment was cloned into the vector pYX142 using EcoRI and XhoI restriction sites 
encoded in the primers. 
3´Ssc1dC239-XhoI: 
5´- ATAT CTCGAG TTA TAA TAA TAA GAC GTC AG - 3´ 
 
pGEM4-b2(87–167)DHFR 
The coding sequence for the yeast cytochrome b2 (amino acid residues 87–167) together 
with the sequence of mouse dihydrofolate reductase (DHFR) was amplified by PCR using 
primers 5´XbaI-cytb2_aa87 and 3´DHFR-PstI and the plasmid pGEM4-cytb2(1–
167)DHFR as a template. The obtained DNA fragment was cloned into the vector pGEM4 
using XbaI and PstI restriction sites encoded in the primers. 
5´XbaI-cytb2_aa87:  
5´- CGAT TCTAGA AAT AAA CAA AAG ATT TCG CC - 3´ 
3´DHFR-PstI: 
5´- ATAT CTGCAG TTA GTC TTT CTT CTC GTA GAC - 3´ 
 
pGEM4-ATPase-b2(87–167)DHFR 
The coding sequence for the ATPase domain of Ssc1 (amino acid residues 1–411) was 
amplified by PCR using primers 5´EcoRI-Ssc1 and 3´ATPase_nostop-XbaI and the 
plasmid pYX142-Ssc1-his as a template. The obtained DNA fragment was cloned into the 
vector pGEM4-b2(87–167)DHFR using EcoRI and XbaI restriction sites encoded in the 
primers. 
3´ATPase_nostop-XbaI: 
5´- ATAT TCTAGA AAC CTC ACC GGA CAA GAC AGC - 3´ 
 
pGEM4-pSu9-PBD-b2(87–167)DHFR 
The coding sequence for the PBD of Ssc1 (amino acid residues 410–654) together with the 
coding sequence for the presequence of subunit 9 of the F1FO ATPase of Neurospora 
crassa on the 5´ end was amplified by PCR using primers 5´EcoRI-Su9-PBD and 
3´Ssc1_nostop-XbaI and the plasmid pYX142-pSu9-PBD-his as a template. The obtained 
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DNA fragment was cloned into the vector pGEM4-b2(87–167)DHFR using EcoRI and 
XbaI restriction sites encoded in the primers. 
5´EcoRI-Su9-PBD:  
5´- ATAT GAATTC ATG GCC TCC ACT CGT GTC - 3´ 
3´Ssc1_nostop-XbaI: 
5´- ATAT TCTAGA CTG CTT AGT TTC ACC AGA TTC G - 3´ 
 
pGEM4-ATPaseLinker-b2(87–167)DHFR 
The coding sequence for the ATPase domain with the subsequent interdomain linker of 
Ssc1 (amino acid residues 1–415) was amplified by PCR using primers 5´EcoRI-Ssc1 and 
3´Ssc1d239_nostop-XbaI and the plasmid pYX142-Ssc1-his as a template. The obtained 
DNA fragment was cloned into the vector pGEM4-b2(87–167)DHFR using EcoRI and 
XbaI restriction sites encoded in the primers. 
3´Ssc1d239_nostop-XbaI: 
5´- ATAT TCTAGA TAA TAA TAA GAC GTC AGT AAC C - 3´ 
 
pGEM4-ATPaseA4-b2(87–167)DHFR 
The coding sequence for the ATPase domain of Ssc1 (amino acid residues 1–411) with the 
additional four alanine residues was amplified by PCR using primers 5´EcoRI-Ssc1 and 
3´Ssc1d239A4_nostop-XbaI and the plasmid pYX142-ATPaseA4-his as a template. The 
obtained DNA fragment was cloned into the vector pGEM4-b2(87–167)DHFR using 
EcoRI and XbaI restriction sites encoded in the primers. 
3´Ssc1d239A4_nostop-XbaI: 
5´- ATAT TCTAGA AGC TGC AGC GGC GTC AGT AACC - 3´ 
 
pGEM4-Ssc1A4 
The Ssc1A4 mutant was generated by an overlap extension PCR method. The coding 
sequences for Ssc1 (amino acid residues 1–411 and 416–654) were amplified by PCR 
using primer pairs 5´EcoRI-Ssc1/3´Ssc1A4_REV and 5´Ssc1A4_FOR/3´Ssc1-Sac1 and 
the plasmid pYX142-Ssc1-his as a template. The primers 3´Ssc1A4_REV and 
5´Ssc1A4_FOR contained sequences encoding four alanine residues. The obtained DNA 
fragments were used as template for the final PCR reaction with primers 5´EcoRI-Ssc1 and 
3´Ssc1-Sac1. The obtained DNA fragment was cloned into the vector pGEM4 using EcoRI 
and SacI restriction sites encoded in the primers. 
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5´Ssc1A4_FOR:   
5´- CT GAC GCC GCT GCA GCA GAT GTT ACC CCA TTG - 3´ 
3´Ssc1A4_REV:   
5´- GT AAC ATC TGC TGC AGC GGC GTC AGT AAC CTC ACC - 3´ 
3´Ssc1-Sac1:    
5´- CCC GAGCTC TTA CTG CTT AGT TTC ACC AGA TTC G - 3´ 
 
2.1.12. Overview of yeast S. cerevisiae strains used 
Strain Description Reference 
FY1679-11a 
Wild-type strain 
corresponding to hep1 
deletion strain 
Euroscarf (10000R) 
hep1 (hep1::KanMX) hep1 deletion strain  
(parental strain: FY1679-11a) 
This thesis 
mif4 
Hsp60-defective temperature-
sensitive mutant strain  
(Cheng et al. 1989) 
[pGALOTC]RP11 
Wild-type strain 
corresponding to mif4 strain 
(Cheng et al. 1989) 
hsp78 (hsp78::URA3) hsp78 deletion strain (Schmitt et al. 1995) 
PK82 
Wild-type strain 
corresponding to hsp78 
strain 
(Gambill et al. 1993) 
mdj1 (mdj1::KanMX) mdj1 deletion strain 
(parental strain: W303-1A) 
Martin Sichting  
(unpublished work) 
W303-1A 
Wild-type strain 
corresponding to mdj1 
strain 
Kind gift from R. 
Rothstein, Columbia 
University, New York 
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2.1.13. Deletion of HEP1 gene in FY 1679-11a yeast strain – generation of hep1 
strain 
HEP1 gene deletion was done by homologous recombination of a PCR product exchanging 
the gene, in the haploid yeast strain FY 1679-11a. The PCR product contained a KANMX 
cassette encoding for resistance against kanamycin and its analogues and short flanking 
sequences homologous to the flanking regions of HEP1 locus, encoded in primers. The 
PCR product was produced using primers 5´hep1_KO and 3´hep1_KO on the plasmid 
pFA6KANMX4 as a template (Wach et al. 1997). The PCR product was transformed into 
yeast and became stably integrated into the chromosome via the regions homologous to the 
HEP1 gene. Positive clones were isolated on YPG medium containing 500 g/ml G418 
(kanamycin analogue) and the HEP1 gene depletion was tested by fast mitochondria 
isolation (2.2.5.1) and immunodecoration against hep1 protein (2.4.1). 
5´hep1_KO: 
5´- TAA TTG TAA TTT TTT TTT CTT GCA TTT TCG CGT GAT ATC AAA ATT CGT ACG 
CTG CAG GTC GAC - 3´ 
3´hep1_KO: 
5´- CGG TTA TAT ATC TAT CTA TGT ACA TGC CTG TGC ATG AGC TCT TCA TAT CGA 
TGA ATT CGA GCT CG - 3´ 
 
2.1.14. Transformation of yeast S. cerevisiae with recombinant DNA 
Yeast cells were transformed with DNA using the lithium acetate method (Gietz et al. 
1992). 50 ml yeast culture was grown at 30 °C with 140 rpm shaking until OD600 = ca. 0.5. 
Cells were harvested by centrifugation for 5 min at 1500 x g and washed once with sterile 
deionized H2O. The cell pellet was resuspended in 1ml 100 mM Li acetate and transferred 
into a 1.5 ml test tube. Cells were harvested again by short centrifugation and resuspended 
in 400 l 100 mM Li acetate. The cell suspension was divided into 50 l aliquots (one 
aliquot per transformation).  Cells were briefly pelleted, and overlayed with 240 l 50 % 
(w/v) PEG 3550, 36 μl 1 M Li acetate, 5 μl heat-denatured, ice-cold salmon-sperm DNA 
(10 mg/ml), 60 μl H2O and 5 μl DNA (0.1–10 μg plasmid DNA or PCR product). Samples 
were vigorously mixed until resuspended and then incubated with shaking at 30 °C for 30 
min and heat-shocked at 42 °C for 25 min. Cells were then briefly pelleted, resuspended in 
150 l sterile deionized H2O and plated on selective media. The plates were incubated at 
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24 °C for 2–10 days until the appearance of single yeast colonies. Transformants were 
tested with PCR and with fast mitochondria isolation, SDS-PAGE and immunodecoration. 
 
2.2. Cell biology methods 
2.2.1. Media for E. coli culture 
Liquid LB medium (Lysogeny broth) 
0.5 % (w/v) yeast extract,  
1 % (w/v) bacto-tryptone,  
1 % (w/v) NaCl 
 
Liquid LB-Amp medium 
LB medium suplemented with 100 g/ml of ampicilin 
 
Liquid SOC medium 
2 % (w/v) bacto-tryptone  
0.5 % (w/v) yeast extract 
8.56 mM NaCl  
2.5 mM KCl  
10 mM MgCl2 
20 mM glucose 
 
All media were prepared in double distilled water and autoclaved. In order to prepare solid 
media (LB or LB-Amp agar plates), liquid LB medium was supplemented with 1.7 % 
(w/v) bacto-agar, autoclaved (120 °C, 20 min) and in the case of LB-Amp plates, 100 
g/ml of ampicilin was added afterwards. 
2.2.2. Cultivation of E. coli cells  
The liquid medium (usually LB-Amp, or LB in the case of cultivation of electrocompetent 
E. coli) was inoculated with a single E. coli colony from the plate and grown overnight at 
37 °C in the case of MH1, XL1Blue and BL21(DE3) strains and at 30 °C in the case of 
BL21(DE3) DnaK strain with shaking at 140 rpm. Then culture was diluted to the desired 
Materials and methods 
 
 32
volume and grown further as described, or directly used for the plasmid isolation or 
preparation of electrocompetent cells. 
2.2.3. Media for yeast S. cerevisiae culture 
YP medium (non-selective) 
1 % (w/v) bacto-peptone,  
1 % (w/v) yeast extract,  
pH adjusted to 5.5 
 
YPG medium (non-selective) 
YP medium supplemented with 3 % glycerol 
 
YPGal medium (non-selective) 
YP medium supplemented with 2 % galactose 
 
Lactate medium (non-selective, semi-synthetic) 
3 g yeast extract,  
1 g KH2PO4,  
1 g NH4Cl,  
0.5 g CaCl2 x 2H2O,  
0.5 g NaCl, 
1.1 g MgSO4 x 6H2O,  
0.3 ml 1 % FeCl3,  
22 ml 90 % lactic acid,  
H2O added to 1 l,  
pH adjusted to 5.5 (using KOH) 
 
SD medium (selective) 
0.17 % yeast nitrogen base,  
0.5 % (NH4)2SO4,  
2 % glucose, 
appriopriate amount of auxotrophic markers, 
H2O added to 1 l 
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SLac medium (selective) 
0.17 % yeast nitrogen base,  
0.5 % (NH4)2SO4,  
22 ml 90 % lactic acid,  
appropriate amount of auxotrophic markers, 
H2O added to 1 l,  
pH adjusted to 5.5 (using KOH) 
 
Auxotrophic markers used for selective media 
20 mg/l adenine sulfate 
20 mg/l uracil 
20 mg/l L-tryptophan 
20 mg/l L-histidine 
30 mg/l L-leucine 
30 mg/l L-lysine 
 
All media were prepared in double distilled water and autoclaved. Glucose, glycerol, 
galactose and selection markers were autoclaved separately and added afterwards to the 
autoclaved medium. In order to prepare corresponding solid media, liquid medium was 
supplemented with 2 % (w/v) bacto-agar autoclaved separately. 
 
2.2.4. Cultivation of S. cerevisiae cells  
Agar plates with yeast cultures were obtained from yeast transformation or inoculated from 
the glycerol stocks (yeast cell suspention in 15 % (v/v) glycerol, stored in -80 °C). Liquid 
cultures were inoculated from the agar plates and grown in appropriate medium usually at  
24 °C, unless otherwise stated, with shaking at 140 rpm. The generated hep1 strain, 
hsp78 strain and the corresponding wild-type (wt) strains were usually grown on lactate 
medium. hep1 strain and the corresponding wt strain over-expressing Ssc1 constructs 
from the pYX142 vector were grown on selective SD medium lacking L-leucine 
(auxotrophic marker). The mif4 strain and the corresponding wt strain were grown on YPG 
medium at 24 °C and shifted to 37 °C 2h prior to isolation of mitochondria. mdj1 strain 
and the corresponding wt strain were grown on YPGal medium. Prior to mitochondria 
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isolation, cells were grown for at least 60 h and diluted accordingly to avoid the OD600 
exceeding 1.5. 
 
2.2.5. Isolation of yeast mitochondria 
2.2.5.1. Fast (crude) mitochondria isolation 
The yeast culture was inoculated from a single colony in 50 ml of the appropriate medium 
and grown overnight at 24 °C with 140 rpm shaking. Yeast cells corresponding to 10 OD 
units were collected by centrifugation at 3000 x g for 5 min (RT), washed with deionized 
water and resuspended in 300 μl SH-KCl buffer containing 1 mM PMSF. Then, 200 μl of 
glass beads of diameter of 0.5–1 mm were added and samples were vigorously vortexed 
four times for 30 sec, with 30 sec intervals between each mixing on ice. Nuclei, broken cell 
debris and glass beads were collected by low-speed centrifugation (1000 x g, 3 min, 4ºC) 
and the supernatant, containing crude mitochondria, was transferred to a new test-tube. 
Mitochondria were collected by high speed centrifugation (17400 x g, 10 min, 4ºC). The 
supernatant, containing cytosolic proteins, was treated with trichloroacetic acid to 
precipitate the proteins. Mitochondrial pellet was directly suspended in 10–50 l of 
Laemmli buffer, unless otherwise stated, and incubated at 95 °C for 5 min. Mitochondrial 
as well as cytosolic protein fractions were analysed by SDS-PAGE and immunodecoration. 
 
SH-KCl buffer 
0.6 M sorbitol,  
20 mM HEPES-KOH pH 7.4,  
80 mM KCl 
2.2.5.2. Large scale isolation of yeast mitochondria 
4–6 litres of yeast culture were grown until the OD600 reached 0.8–1.5. Cells were collected 
by centrifugation (3000 x g, 5 min, RT) and washed once with deionized water. After the 
measuring of their wet weight, cells were resuspended in 100 mM TRIS base, 10 mM DTT 
to a concentration of 0.5 g cells/ml, to facilitate spheroplast formation. Cells were 
incubated at 30 °C for 15 min with 140 rpm shaking. Next, cells were collected by 
centrifugation (3000 x g, 5 min, RT), washed once with 1.2 M sorbitol and resuspended in 
zymolyase buffer to a concentration of 0.15 g cells/ml, in order to digest the yeast cell wall 
and form spheroplasts. Cells were incubated in zymolyase buffer for 30–60 min at 30 °C 
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with 140 rpm shaking. Then, spheroplasts were collected by centrifugation (3000 x g, 5 
min, 4 °C), resuspended in ice-cold homogenization buffer to a concentration of 0.15 g 
cells/ml and homogenized 10 times in a cooled glass dounce homogenizer on ice. 
Homogenized suspension was centrifuged two times (2000 x g, 5 min, 4 °C) to get rid of 
cell debris, unbroken cells and nuclei. The supernatant, containing mitochondria, was 
poured to a new tube and the mitochondria were collected by centrifugation (17400 x g, 12 
min, 4 °C). Mitochondrial pellet was resuspended in ice-cold SH buffer and centrifuged 
two times at a low speed (2000 x g, 5 min, 4 °C), to get rid of remaining impurities. 
Finally, isolated mitochondria were collected by high-speed centrifugation (17400 x g, 12 
min, 4 °C), the mitochondrial pellet was resuspended in 0.5–1 ml of ice-cold SH buffer and 
the mitochondrial protein concentration was determined by the Bradford assay (2.3.5). The 
protein concentration was adjusted to 10 mg/ml with SH buffer and the mitochondrial 
solution was aliquoted (30–50 l per test-tube), frozen in liquid N2 and stored at -80 °C.  
 
Zymolyase buffer 
1.2 M sorbitol, 
20 mM KH2PO4-KOH pH 7.4  
4 mg zymolyase per 1 g of cells 
 
SH buffer 
0.6 M sorbitol,  
20 mM HEPES-KOH pH 7.4 
Homogenization buffer 
0.6 M sorbitol, 
10 mM TRIS-HCl pH 7.4,  
1 mM EDTA,  
0.2 % (w/v) BSA (fatty acid free),  
1 mM PMSF 
 
 
2.2.6. Sucrose gradient fractionation of mitochondrial proteins 
Isolated mitochondria containing 200 g of proteins were solubilized in lysis buffer at a 
concentration of 1 mg/ml for 30 min at 4 °C and subjected to a claryfying spin of 10,000 x 
g for 5 min. The pellet after the clarifying spin was directly suspended in 1 x Laemmli 
buffer and incubated for 5 min at 95 °C. Supernatant, containing mitochondrial lysate, was 
layered onto 4 ml of a continuous sucrose gradient (10 % to 30 % of sucrose) and 
centrifuged for 40 min at 485,000 x g at 4 °C using the SW 60 Ti rotor (Beckman Coulter). 
The gradient was fractionated into 500 l fractions, starting from the bottom-most fraction, 
using a custom-made fractionation device. The proteins of the fractions were precipitated 
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by TCA and the samples were analysed by SDS-PAGE and immunodecoration with the 
indicated antibodies. 
 
Lysis buffer 
20 mM TRIS-HCl pH 7.4, 
80 mM KCl, 
1 % (v/v) Triton X-100,  
1 mM PMSF 
 
2.2.7. Protein aggregation assay 
To determine the solubility of mitochondrial proteins, an aggregation assay was performed. 
Isolated mitochondria were pre-incubated for 15 min at 30ºC and then solubilized in the 
lysis buffer (2.2.6) at a protein concentration of 1 mg/ml for 30 min on ice. Half of the 
sample was removed as control of total protein. The other half was centrifuged at 36000 x 
g for 10 min at 4ºC to separate the soluble (Supernatant) and insoluble (Pellet) fractions. 
Total and supernatant were precipitated with TCA (2.3.4). Samples corresponding to 20–
30 g of mitochondrial proteins were analysed by SDS-PAGE and immunodecoration 
against the indicated proteins. 
 
2.2.8. Aggregation assay of Hsp60 
To analyse the solubility of Hsp60 in the mif4 and the corresponding wild-type strain, cells 
were grown at 24 °C until mid-logarithmic phase, then shifted to 37 °C and grown further 
for 2.5 h. Next, cells corresponding to 3 OD units were collected by centrifugation at 3000 
x g for 3 min, washed once with water and resuspended in 20 mM TRIS-HCl pH 7.4, 80 
mM KCl, 1 mM PMSF. Then, 200 μl of glass beads of diameter 0.5–1 mm were added and 
samples were vigorously vortexed four times for 30 sec with 30 sec intervals on ice 
between mixings. The glass beads were collected by low-speed centrifugation (1000 x g, 5 
sec), the broken cell suspension was transferred to a fresh tube and 1 % (v/v) of Triton X-
100 was added. Cells were lysed on ice for 30 min. After a clarifying spin at 1000 x g, cell 
lysate was transferred to the fresh tube and centrifuged at 15000 x g for 15 min at 4 °C to 
separate the soluble and insoluble fraction. The soluble fraction was precipitated with TCA 
(2.3.4). The insoluble fraction was directly suspended in 1 x Laemmli buffer. Samples 
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were analysed by SDS-PAGE and immunodecoration with antibodies against bacterial 
GroEL that recognize yeast Hsp60. 
 
2.2.9. Chemical cross-linking of mitochondrial proteins in organello 
To analyse the interactions between mitochondrial proteins, the proteins were chemically 
cross-linked using DSG (disuccinimidylglutarate), a membrane-permeable, lysine-specific 
cross-linking reagent. Mitochondria were suspended in the standard import buffer (2.2.10) 
lacking BSA, at a protein concentration of 1 mg/ml, with addition of 10 U/ml apyrase and 
10 μM oligomycin to deplete ATP. The samples were incubated for 10 min at 37ºC. DSG 
dissolved in DMSO was added to the samples to a final concentration of 150 µM. Samples 
were incubated for 30 min on ice and then the remaining cross-linking reagent was 
quenched by addition of 0.1 M glycine, pH 8.8 for 10 min on ice. Mitochondria were re-
isolated and cross-linked adducts were analysed by SDS-PAGE and immunodecoration. 
When the adducts were to be isolated via his-tag on NiNTA beads, 150 μg of re-isolated 
mitochondria were solubilized in the solubilization buffer, at a protein concentration of 1 
mg/ml, for 30 min on ice. After a clarifying spin at 125000 x g for 20 min at 4 °C, an 
aliquot of total (5 %) was taken out and the rest was added to 60 μl (bed volume) of 
NiNTA-agarose beads. After 2 h of incubation at 4 °C with gentle mixing, the beads were 
pelleted, a sample (5 %) of non-bound material was taken out and the rest of the 
supernatant was removed. The beads were washed 3 times with 500 μl of the washing 
buffer. The bound proteins and protein adducts were eluted by 1 x Laemmli buffer 
supplemented with 300 mM imidazole and heating at  
95 °C for 5 min. Total (5 %), non-bound (5 %) and eluted material (100 %) was analysed 
by SDS-PAGE and immunodecoration. 
 
Solubilization buffer 
20 mM TRIS-HCl pH 7.4, 
80 mM K-acetate, 
20 mM imidazole, 
10 % (v/v) glycerol, 
1 % (v/v) Triton X-100, 
1 x Complete Protease Inhibitor Cocktail 
(Roche) 
Washing buffer 
20 mM TRIS-HCl pH 7.4, 
80 mM K-acetate, 
20 mM imidazole, 
10 % (v/v) glycerol, 
0.05 % (v/v) Triton X-100, 
1 x Complete Protease Inhibitor Cocktail 
(Roche) 
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2.2.10. Import of radiolabelled pre-proteins into isolated mitochondria and folding 
assay 
Mitochondria were resuspended to a final protein concentration of 0.5 mg/ml in the 
standard import buffer supplied with 5 mM NADH, 2.5 mM ATP, 10 mM creatine 
phosphate and 100 μg/ml of creatine kinase. After pre-incubation for 3 min at 25 °C, 1–3 
% (v/v) of radiolabelled pre-protein lysate was added and the import reaction was 
performed for various time periods at 25 °C. Pre-protein import was stopped by addition of 
9 volumes of ice-cold SH buffer (2.2.5.2) containing 2 M valinomycin. Non-imported 
material was digested by 50 μg/ml trypsin for 15 min on ice. Protease treatment was 
stopped by addition of 20-fold excess of soybean trypsin inhibitor (STI) and incubation for 
10 min on ice. Mitochondria were re-isolated by centrifugation at 26500 x g for 12 min at 4 
°C. Mitochondrial pellets were washed once with 500 μl of SH-KCl buffer (2.2.5.1), and 
solubilized with the lysis buffer for 15 min on ice at a protein concentration of 1 mg/ml. 
The samples were halved, one half was mock-treated and the other half was digested with 
50 μg/ml of trypsin for 10 min on ice to assess the folding state of the imported protein. 
The trypsin reaction was stopped by TCA precipitation and the samples were analysed by 
SDS-PAGE and autoradiography. 
 
Standard import buffer 
600 mM sorbitol,  
50 mM HEPES-KOH pH 7.2, 
80 mM KCl,  
0.01 % (w/v) BSA (fatty acid free),  
10 mM Mg-acetate, 
2.5 mM EDTA,  
2 mM K-phosphate, 
1 mM MnCl2 
Lysis buffer 
20 mM TRIS-HCl pH 7.5 
80 mM KCl 
1 % (v/v) Triton X-100 
 
 
2.2.11. In vivo labelling 
hep1 and wild-type cells were grown in lactate medium until the OD600 = 0.5–1. Cells 
were harvested by centrifugation at 3000 x g for 5 min at 25 °C (5 OD units per sample) 
and resuspended in Slac medium at a concentration of 5 OD units/ml. Then 0.5 % (v/v) of 
35S-methionine (activity of 10 mCi/ml) was added and cells were grown for a further 10 
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min at 25ºC. Next, 100 g/ml of cycloheximide to stop the protein synthesis and 10 mM 
cold methionine were added and cells were further grown for the indicated time periods. 
Cells were harvested by centrifugation at 10000 x g for 1 min at 25 °C, resuspended in SH-
KCl buffer (2.2.5.1) supplemented with 1 mM PMSF and disrupted by shaking with glass 
beads of a diameter of 0.5–1 mm at 4ºC. Crude mitochondria were isolated as described in 
2.2.5.1 and solubilized in the lysis buffer (2.2.10) for 15 min on ice. Samples were halved; 
one half was mock-treated, the other half was digested with 2.5 g/ml of trypsin for 10 min 
on ice. Digestion was stopped by TCA precipitation and protein pellet was resuspended in 
10 l of 1 % (m/v) SDS, 100 mM TRIS-HCl pH 7.4 and incubated at 95 °C for 5 min. 
Next, samples were diluted 20-times with IP buffer (2.4.2) and, after a clarifying spin at 
125000 x g for 20 min at 4 °C, subjected to immunoprecipitation with antibodies against 
Ssc1 (2.4.2). Samples were analysed by SDS-PAGE, autoradiography and quantification. 
 
2.3. Protein biochemistry methods 
2.3.1. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
A one-dimensional, vertical, discontinuous SDS-PAGE system was used to separate 
proteins according to their molecular sizes under denaturing conditions (Laemmli 1970). 
Depending on the size of a protein of interest, various concentrations of acrylamide and 
bis-acrylamide were used to prepare the separating gel. Gel dimensions were 
approximately 14 cm x 9 cm x 0.1 cm for the separating gel and 14 cm x 1 cm x 0.1 cm for 
the stacking gel. Protein samples were suspended in 10–50 l of 1 x Laemmli buffer and 
incubated at 95 °C for 5 min prior to loading. In order to estimate the size of separated 
proteins, unstained protein molecular weight marker (Fermentas) was used. 
Electrophoresis was carried out for 90–120 min at 35 mA. Separated proteins were stained 
with Coomassie Brilliant-blue solution (2.3.3) or transferred onto a nitrocellulose 
membrane (Western blot) (2.3.2). 
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Separating gel 
8–16 % (w/v) acrylamide,  
0.16–0.33 % (w/v) bis-acrylamide,  
375 mM TRIS-HCl pH 8.8,  
0.1 % (w/v) SDS,  
0.05 % (w/v) APS,  
0.05 % (v/v) TEMED 
 
Electrophoresis buffer 
50 mM TRIS base,  
384 mM glycin,  
0.1 % (w/v) SDS,  
pH 8.3 (not adjusted) 
Stacking gel 
5 % (w/v) acrylamide,  
0.1 % (w/v) bis-acrylamide,  
60 mM TRIS-HCl pH 6.8,  
0.1 % (w/v) SDS,  
0.05 % (w/v) APS,  
0.05 % (v/v) TEMED 
 
1 x Laemmli buffer 
60 mM TRIS-HCl pH 6.8,  
2 % (w/v) SDS,  
10 % glycerol,  
5 % (v/v) -mercaptoethanol,  
0.05 % (w/v) bromphenol-blue 
 
2.3.2. Protein transfer onto the nitrocellulose membrane (Western blot) 
Proteins separated by SDS-PAGE were transferred electrophoretically onto the 
nitrocellulose membranes using a semi-dry transfer method. The nitrocellulose membrane 
(Protran, Whatman), blotting paper (Macherey-Nagel, MN 440 B) and the polyacrylamide 
gel after SDS-PAGE were soaked in the blotting buffer. Next, a blotting ‘sandwich’ was 
assembled in the custom-made blotting chamber consisting of graphite electrodes, in the 
following order: one sheet of blotting paper, the nitrocellulose membrane, the 
polyacrylamide gel and one sheet of blotting paper. Electrotransfer was carried out at 250 
mA for 70 min. After the transfer, the membrane was briefly washed in water and stained 
with the Ponceau S solution, to visualize transferred proteins. Transferred proteins were 
further analysed by immunodecoration or, in the case of radioactive proteins, by 
autoradiography. 
 
Blotting buffer 
20 mM TRIS base,  
150 mM glycin, 
20 % (v/v) methanol, 
0.08 % (w/v) SDS 
Ponceau S solution 
0.2 % (w/v) Ponceau S, 
3 % (w/v) TCA 
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2.3.3. Coomassie Brilliant-blue staining of SDS-polyacrylamide gels 
Separating gels after SDS-PAGE were washed with deionized water. Then, the staining 
solution was added. Gels were incubated in the staining solution for 1–3 h, washed with 
deionized water and incubated in several portions of destaining solution until the protein 
bands were clearly visible and the rest of the gel was colorless. 
Staining solution 
30 % (v/v) methanol,  
10 % (v/v) acetic acid, 
0.1 % (w/v) Coomassie-Brilliant-blue G-250 
 
Destaining solution 
30 % (v/v) methanol  
10 % (v/v) acetic acid 
 
2.3.4. Protein precipitation with TCA (trichloroacetic acid) 
Proteins were precipitated from aqueous solutions by addition of TCA to a final 
concentration of 12 % (v/v). Samples were incubated at -20 °C for at least 30 min, thawed 
on ice and centrifuged at 39000 x g for 20 min at 4 °C. The pellets of precipitated proteins 
were washed with -20 °C acetone, dried for 2 min at 30 °C, dissolved in 1 x Laemmli 
buffer and heated at 95 °C for 5 min. 
 
2.3.5. Determination of protein concentration 
Protein concentration was determined using the Bradford assay (Bradford 1976). The 
protein solution (1–10 μl) was added to 1 ml of 5-fold diluted Protein Assay reagent (Bio-
Rad). The samples were mixed and incubated for 10 min at RT. The absorbance of the 
samples was measured at 595 nm in a 1 cm path-length cuvette. The protein concentration 
was determined from a calibration curve prepared with a solution of bovine IgG proteins 
(Bio-Rad) of known concentration as a standard. 
 
2.3.6. NiNTA pull-down of proteins from mitochondria 
To analyse the interactions between mitochondrial proteins, pull-down experiments of 
proteins containing a his-tag were carried out. Isolated mitochondria (150 g) were 
suspended in the standard import buffer (2.2.10) with addition of 10 U/ml apyrase and 10 
μM oligomycin to deplete ATP. Samples were incubated for 10 min at 37ºC. Then, 
mitochondria were re-isolated and solubilized at a concentration of 1 mg/ml in 
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solubilization buffer for 30 min at 4 °C. After a clarifying spin at 125000 x g for 20 min at 
4 °C, an aliquot of total (20 %) was taken out and the rest of the solubilized material was 
incubated with 50 µl (bed volume) of NiNTA-agarose beads for 2h at 4 °C with gentle 
turn-over mixing. The beads were then pelleted, and a fraction of non-bound material (FT, 
20 %) was taken out. The rest of the supernatant was removed, beads were washed 3 times 
with 500 ml of washing buffer and bound proteins were eluted with 1 x Laemmli buffer 
containing 300 mM imidazole and heating at 95 °C for 5 min. Total (20 %), supernatant 
(20 %) and elution (100 %) fractions were then subjected to SDS-PAGE and 
immunodecoration. 
 
Solubilization buffer 
20 mM TRIS-HCl pH 8.0, 
80 mM K-acetate, 
20 mM imidazole, 
10 % (v/v) glycerol, 
1 % (v/v) Triton X-100, 
1 mM PMSF 
Washing buffer 
20 mM TRIS-HCl pH 8.0, 
80 mM K-acetate, 
20 mM imidazole, 
10 % (v/v) glycerol, 
0.05 % (v/v) Triton X-100, 
1 mM PMSF 
 
2.3.7. In vitro synthesis of radiolabelled pre-proteins 
The coding sequences for pre-proteins were cloned into the pGEM4 vector under the 
control of Sp6 promoter. These coding sequences were transcribed into mRNA using SP6 
RNA polymerase and subsequently translated using rabbit-reticulocyte lysate in the 
presence of 35S-methionine. 
The transcription mixture was prepared on ice and incubated for 1 h at 37ºC. Following 
addition of 10 μl 10 M LiCl and 600 μl absolute ethanol, the sample was incubated at -20 
°C for 30 min and precipitated mRNA was isolated by centrifugation at 36670 x g for 30 at 
4ºC. The RNA pellet was washed with ice-cold 70 % (v/v) ethanol, dried for 3 min at 30 
°C, resuspended in 50 μl H2O supplemented with 0.6 μl RNAsin and used for in vitro 
translation or stored at -80 °C.  
The translation mixture was prepared on ice and incubated for 1 h at 30 °C. Then, 8 μl of  
58 mM non-labelled methionine (chase) and 16 μl of 1.5 M sucrose were added. Next, the 
sample was centrifugated at 90700 x g for 45 min at 2ºC to remove ribosomes and 
aggregated proteins. The supernatant was divided into aliquots and stored at – 80ºC. 
Materials and methods 
 
 43
 
Premix: 
40 mM HEPES-KOH pH 7.4 
6 mM Mg-acetate 
2 mM spermidin 
0.1 mg/ml BSA 
10 mM DTT 
0.5 mM ATP, CTP, GTP, UTP each 
Transcription mixture 
60 μl Premix,  
10 μl 2.5 mM m7G(5´)ppp(5´)G,  
20 μg plasmid DNA,  
2.3 μl RNasin (40 U/μl),  
0.8 μl Sp6 polymerase 
H2O added to 100 μl 
 
Translation mixture 
70 μl rabbit reticulocyte lysate (Promega),  
2 μl RNAsin (20 U),  
2 μl amino acid mix (1mM each, without methionine),  
8 μl 35S-methionine, 
16 μl mRNA 
 
2.3.8. Detection and quantification of radiolabelled proteins 
Radiolabelled proteins after SDS-PAGE and Western blot were detected by 
autoradiography. The dry nitrocellulose membrane with radioactive signal was exposed to 
an X-ray film (Kodak Bio Max MM) for a desired time period, depending on the signal 
intensity (1–120 days). Then, the film was developed in a developing machine (Gevamatic 
60, AGFAGevaert). The films were scanned and the intensity of bands of interest was 
quantified by densitometry using Image Master 1D Elite software (Amersham). 
 
2.3.9. Purification of recombinant his-tagged proteins 
Recombinant his-tagged proteins were purified using NiNTA affinity chromatography. 
His-tagged mature Hep1 was over-expressed in XL1Blue strain of E. coli and his-tagged 
PBD and his-tagged mature Mge1 were over-expressed in BL21 (DE3) DnaK strain of E. 
coli.  
A 50 ml LB-Amp starter culture was inoculated from a single bacterial colony transformed 
with the appropriate plasmid and grown overnight at 37 °C. Starter culture was used to 
inoculate 500 ml of LB-Amp to an OD600 of 0.05–0.12. Bacteria were grown at 37 °C with 
shaking until OD600 = 0.5 and then expression of the protein of interest was induced by 
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adding 0.5–1 mM IPTG. After 3 h of induction, bacteria were collected by centrifugation 
at 4400 x g for 15 min at 25 °C, washed once with water and the bacterial pellet was frozen 
at -20 °C. After 30 min of incubation at -20 °C, bacterial pellet was thawed and 
resuspended in 20 ml of buffer A. To destroy the cell wall, 1 mg/ml of Lysozyme (Sigma) 
was added and the solution was incubated for 45 min at 4 °C with mild shaking. Next, cells 
were disrupted by sonication in an ice-bath using a Branson Sonifier (10 x 12 sec, 10 sec 
pause, setting 4, 80 % duty cycle). Unbroken cells and cell debris was removed by 
centrifugation at 27200 x g for 15 min at 4 °C and the supernatant, containing over-
expressed proteins, was loaded onto the previously prepared NiNTA column. To prepare 
the column, 0.75 ml of NiNTA-agarose beads were loaded into the empty column, left to 
settle and washed with 20 ml of deionized water. The column was then equilibrated with 
20 ml of buffer A. After passing the bacterial lysate through the column at a flow rate of 1 
ml/min, the column was washed with 15 ml of buffer A and the bound his-tagged proteins 
were eluted with buffer A supplemented with 300 mM imidazole. The eluate was collected 
in 1 ml aliquots, the fractions containing the most protein were pulled together and the 
buffer was exchanged to the storage buffer using PD-10 Desalting column (GE 
Healthcare). After determination of the protein concentration (2.3.5), the protein solution 
was divided into aliquots, frozen in liquid nitrogen and stored at -80 °C. 
 
Buffer A 
20 mM HEPES-KOH pH 7.4, 
250 mM KCl, 
20 mM imidazole, 
2 mM β-mercaptoethanol, 
10 % (v/v) glycerol, 
1 mM PMSF 
Storage buffer 
20 mM HEPES-KOH pH 7.4, 
100 mM KCl, 
5 mM MgCl2, 
5 % (v/v) glycerol 
 
 
2.3.10. Purification of recombinant Ssc1 and the ATPaseLinker domain 
To purify mature recombinant Ssc1 and ATPaseLinker, the Mge1-affinity column was 
used. To prepare this column, BL21 (DE3) DnaK cells over-expressing his-tagged Mge1 
protein were grown, induced, harvested and treated as described in 2.3.9. Similarly, Mge1-
containing bacterial lysate was passed through the NiNTA-agarose column and washed 
with 15 ml of buffer A (2.3.9). Bound Mge1 protein was, however, not eluted from the 
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column. Instead, the column was washed with 15 ml of buffer D and with 15 ml of buffer 
E. Finally, it was re-equilibrated with 20 ml of buffer A. Such prepared Mge1-affinity 
column was ready for Ssc1 or ATPaseLinker purification. 
Mature, recombinant Ssc1 and ATPaseLinker were over-expressed in BL21 (DE3) DnaK 
strain of E. coli. 50 ml LB-Amp pre-culture was inoculated from a single bacterial colony 
transformed with the appropriate plasmid and grown overnight at 30 °C. Pre-culture was 
used to inoculate 1 litre of LB-Amp to an OD600 of 0.05–0.12. Bacteria were grown at 30 
°C with shaking until the OD600 = 0.5, and then expression of the protein of interest was 
induced by addition of 1 mM IPTG. After 3 h of induction, bacteria were collected by 
centrifugation at 4400 x g for 15 min at 25 °C, washed once with water and the bacterial 
pellet was frozen at -20 °C. After 30 min incubation at -20 °C, bacterial pellet was thawed 
and resuspended in 40 ml of buffer A. To destroy the cell wall, 1 mg/ml of Lysozyme 
(Sigma) was added and the solution was incubated for 45 min at 4 °C with mild shaking. 
Next, cells were disrupted by sonication in an ice-bath using a Branson Sonifier (10 x 12 
sec, 10 sec pause, setting 4, 80 % duty cycle). Unbroken cells and cell debris were 
removed by centrifugation at 27200 x g for 15 min at 4 °C and the supernatant containing 
the over-expressed protein was passed two times through the Mge1-affinity column at a 
flow rate of 1 ml/min. The column was then washed with 15 ml of buffer A and with 20 ml 
of buffer D. Finally, the bound Ssc1 or ATPaseLinker was slowly eluted with buffer E 
(flow rate 0.2 ml/min). The eluate was collected in 1 ml aliquots, the fractions containing 
the most protein were pulled together and the buffer was exchanged to the storage buffer 
(2.3.9) using PD-10 Desalting column (GE Healthcare). After determination of the protein 
concentration (2.3.5), the protein solution was divided into aliquots, frozen in liquid 
nitrogen and stored at -80 °C. 
 
Buffer D 
20 mM HEPES-KOH pH 7.4, 
250 mM KCl, 
2 mM β-mercaptoethanol, 
10 % (v/v) glycerol, 
1 mM PMSF 
 
Buffer E 
20 mM HEPES-KOH pH 7.4, 
250 mM KCl, 
2 mM β-mercaptoethanol, 
10 % (v/v) glycerol, 
1 mM PMSF 
10 mM MgCl2, 
5 mM ATP 
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2.3.11. Purification of recombinant his-tagged DnaJ 
Recombinant his-tagged DnaJ was over-expressed in BL21 (DE3) DnaK strain of E. coli 
and purified using NiNTA affinity chromatography. 500 ml of bacterial culture was grown, 
induced and collected as described for his-tagged proteins (2.3.9). The bacterial pellet was 
frozen at -20 °C, thawed after 30 min and resuspended in 20 ml of sonification buffer. To 
destroy the cell wall, 1 mg/ml of Lysozyme (Sigma) was added and the solution was 
incubated for 45 min at 4 °C with mild shaking. Next, cells were disrupted by sonication in 
an ice-bath using a Branson Sonifier (10 x 12 sec, 10 sec pause, setting 4, 80 % duty 
cycle). Cell debris containing DnaJ was collected by centrifugation at 27200 x g for 30 min 
at 4 °C and the supernatant was discarded. Pellet was resuspended in 20 ml of buffer AJ 
and incubated for 1 h at 4 °C with mild agitation. Cell debris was pelleted again at 27200 x 
g for 30 min at 4 °C and 0.5 ml of previously washed NiNTA-agarose beads were added to 
the supernatant, containing extracted DnaJ. The mixture was incubated for 2 h at 4 °C 
while shaking, and then beads were used to pack an empty column and the flow-through 
was collected. The column was subsequently washed with 10 ml of buffer BJ and with 10 
ml of buffer CJ. Bound DnaJ was eluted with 10 ml of buffer EJ. Eluate was collected in 
0.5 ml aliquots, the fractions containing the most protein were pulled together and the 
buffer was exchanged to the storage buffer J using PD-10 Desalting column (GE 
Healthcare). After determination of the protein concentration (2.3.5), the protein solution 
was divided into aliquots, frozen in liquid nitrogen and stored at -80 °C. 
 
Sonification Buffer 
50 mM TRIS-HCl pH 8.0, 
10 mM DTT, 
10 mM EDTA, 
0.6 % (m/v) Brij 58 
 
Buffer AJ 
50 mM TRIS-HCl pH 8.0, 
2 M urea, 
5 mM DTT, 
500 mM KCl, 
20 mM imidazole, 
0.1 % Triton X-100, 
Buffer CJ 
50 mM TRIS-HCl pH 8.0, 
5 mM DTT, 
500 mM KCl, 
20 mM Imidazole, 
0.05 % (m/v) Brij 58, 
10 % (v/v) glycerol 
 
Buffer EJ 
50 mM TRIS-HCl pH 8.0, 
5 mM DTT, 
500 mM KCl, 
0.05 % (m/v) Brij 58, 
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10 % (v/v) glycerol, 
1 mM PMSF 
 
Buffer BJ 
50 mM TRIS-HCl pH 8.0, 
5 mM DTT, 
500 mM KCl, 
20 mM imidazole, 
0.1 % Triton X-100, 
10 % (v/v) glycerol 
 
10 % (v/v) glycerol, 
100 mM EDTA 
 
Storage buffer J 
20 mM HEPES-KOH pH 7.4, 
250 mM KCl, 
5 mM DTT, 
0.05 % (m/v) Brij 58, 
10 % (v/v) glycerol 
 
2.3.12. Unfolding of recombinant proteins by urea 
Recombinant protein to be unfolded was first precipitated by ammonium sulfate. 2/3 of 
volume of saturated solution of ice-cold ammonium sulfate was added 3 times to the 
solution of recombinant protein, with vigorous vortexing in between. The sample was 
incubated on ice for 30 min and the precipitated protein was collected by centrifugation at 
15000 x g for 12 min at 4 °C. The supernatant was removed and the protein pellet was 
resuspended in urea buffer to the final concentration of 6 mg/ml. Samples were stored at -
20 °C and incubated for 10 min at 25 °C each time prior to use. 
 
Saturated solution of ammonium sulfate 
35.2 g ammonium sulfate, 
H2O added to 50 ml, 
pH 7.0 adjusted with KOH 
 
Urea buffer 
8 M urea,  
20 mM TRIS-HCl, pH 7.4 
 
2.3.13. Refolding assay 
Recombinant proteins were precipitated with ammonium sulfate and unfolded by 
resuspension in the urea buffer (2.3.12). Samples were diluted 20-fold in the refolding 
buffer to an unfolded protein concentration of 0.3 mg/ml. 0.1 mg/ml of yeast cytochrome c 
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(Sigma) was added to block unspecific interactions. When stated, Hep1 or Mge1 (the 
amounts indicated) and/or 2.5 mM of the indicated nucleotides were added. Samples were 
incubated at 25ºC for the indicated time periods to allow protein refolding. Aliquots 
containing 6 g of the refolding protein were withdrawn, diluted in one volume of ice-cold 
refolding buffer, placed on ice and 5 g/ml of trypsin was added, where indicated. Input 
samples were mock-treated, as a control. After 15 min at 4ºC, Soybean trypsin inhibitor 
(STI) was added to all samples, and a clarifying spin at 39000 x g for 10 min at 4 °C was 
carried out. Supernatants were diluted in 1 x Laemmli buffer and heated for 5 min at 95 °C. 
Samples were analysed by SDS-PAGE and Coomassie staining. 
 
Refolding buffer 
20 mM HEPES-KOH pH 7.4, 
100 mM KCl, 
5 mM MgCl2, 
5 % (v/v) glycerol 
 
2.3.14. ATPase activity assays 
2.3.14.1. Enzymatic ATPase assay 
The ATPase activity of recombinant native Ssc1 and Ssc1 after refolding was measured 
using a colorimetric assay based on an ATP-regenerating enzyme system (Norby 1988). In 
this assay, ATP consumption is coupled to the oxidation of NADH to NAD+ that can be 
monitored photometrically at 360 nm. Ssc1 (4.3 M) was incubated for 20 min at 25ºC in 
refolding buffer with 8.3 mM ATP and 0.3 mg/ml BSA, and, where indicated, 8.6 M 
Hep1, in a total volume of 60 l. Samples were diluted 4.3-fold in refolding buffer (3.13) 
equilibrated for 3 min at 25 °C, containing 0.12 mM NADH, 3 mM phosphoenolpyruvate, 
10 U of lactate dehydrogenase (Sigma), 15 U of pyruvate kinase (Sigma), 2 M Mge1 and 
2 M DnaJ. The change of absorbance at 360 nm at 25ºC was monitored over time by a 
spectrophotometer (JASCO, Gross-Umstadt, Germany), and converted to the consumption 
of mol of ATP per mol of Ssc1 per min. 
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2.3.14.2. Radioactive ATPase assay  
5 g of Ssc1 (native or unfolded) was incubated in a total volume of 20 l of ATPase 
buffer, in the presence or absence of 2.5 g recombinant Hep1, at 25 °C for 20 min to 
allow potential Ssc1 refolding. Then, 3.38 g of recombinant Mge1, 6.08 g of 
recombinant DnaJ and γ-32P-ATP (final conc. of  0.1 mM) was added and samples were 
further incubated at 25 °C. After 5, 10 and 20 min, 3 l aliquots were taken out and the 
reaction was stopped by adding 3 l of stop buffer and cooling on ice. Finally, 2 l of 
samples were spotted on PEI-Cellulose F Thin Layer Chromatography plates and the 
samples were developed in 1 M LiCl for 45 min at 25 °C. Afterwards, plates were dried, 
covered with plastic foil and exposed to phosphoimager plates. The signal of radiolabelled 
ATP, ADP and released phosphate was visualised and quantified by phosphoimager (Fuji 
Bas3000, Aida Image Analyser). 
 
ATPase buffer 
50 mM HEPES-KOH pH 7.4,  
100 mM KCl,  
5 mM MgCl2, 
400 mM urea (in the case of folded Ssc1) 
5 mM ATP (unlabelled) 
Stop buffer 
100 mM EDTA pH 8.0 
10 mM ATP (unlabelled) 
10 mM ADP (unlabelled) 
 
 
2.3.15. Crosslinking of recombinant proteins 
Chemical crosslinking in vitro was performed using the non-specific crosslinking reagent 
glutaraldehyde. Unfolded Ssc1 (3 M) was initially incubated for 20 min at 30ºC in 
crosslinking buffer in a final volume of 20 l. Where indicated, 6 M Hep1, 6 M Mge1 
and/or 2.5 mM of the indicated nucleotide were added to the sample prior to the initial 
incubation. In the case of chase experiments, 2.5 mM of indicated nucleotides were added 
after the initial incubation and samples were further incubated for 10 min at 30 °C. Next, 
glutaraldehyde was added to a final concentration of 1 mM and samples were incubated for 
30 min at 30 °C. Finally, samples were suspended in 1 x Laemmli buffer containing 200 
mM of glycine to quench the remaining glutaraldehyde, and samples were heated to 95 °C 
for 5 min and analysed by SDS-PAGE and immunodecoration. 
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Crosslinking buffer 
50 mM HEPES-KOH pH 7.4,  
200 mM NaCl,  
100 mM KCl,  
5 mM MgCl2 
 
2.4. Immunology methods 
2.4.1. Immunodecoration 
Proteins transferred to the nitrocellulose membrane (2.3.2) were visualized by 
immunodecoration with specific antibodies.  The membrane was first incubated for 30 min 
in blocking solution to block all non-specific binding sites. Then, the membrane was 
incubated in primary antibody solution (diluted 100–10000-fold in blocking solution) with 
gentle shaking/rolling for 1.5 h at 25 °C or, alternatively, at 4 °C overnight. The antibody 
solution was collected and stored at -20 °C to be re-used. The membrane was washed 
subsequently with TBS, TBS containing 0.05 % (v/v) Triton X-100 and TBS, each 
washing step for ca. 5–10 min. Afterwards, a fresh solution of secondary antibody 
conjugated with horseradish peroxidase (HRP) (diluted 10000 times in blocking solution) 
was prepared and the membrane was incubated in it for 30–60 min at 25 °C or, 
alternatively, at 4 °C overnight. The membrane was washed similarly as after the primary 
antibody treatment and covered with the fresh chemiluminescent substrate (ECL reagent 1 
and 2 mixed in 1:1 ratio) of peroxidase. Chemiluminescence was detected on X-ray films 
(Fuji New RX) and the films were developed in a developing machine (Gevamatic 60, 
AGFAGevaert). 
 
TBS 
135 mM NaCl,  
10 mM TRIS-HCl pH 7.5 
 
Blocking solution 
5 % (m/v) milk powder 
TBS 
 
ECL reagent 1 
100 mM TRIS-HCl pH 8.5,  
0.44 mg/ml luminol, 
67 μg/ml p-coumaric acid 
ECL reagent 2 
100 mM TRIS-HCl pH 8.5,  
0.03 % (v/v) H2O2 
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2.4.2. Immunoprecipitation 
40 l (bed volume) of Protein A-Sepharose CL-4B beads (GE Healthcare) were pre-
washed 3 times with 1 ml of TBS (4.1). Then, antibodies against Ssc1 (50 l) were coupled 
to the beads by 30 min of incubation at 4 °C with gentle agitation. Finally, beads were 
washed 2 times with 1 ml of TBS and once with 1 ml of IP buffer. 
Protein pellets after TCA precipitation were resuspended in 1 % (w/v) SDS, 100 mM 
TRIS-HCl pH 7.4 and incubated at 95 °C for 5 minutes. Next, samples were diluted 30-
times in IP buffer and, after a clarifying spin at 125000 x g for 20 min at 4 °C, added to the 
washed protein A-sepharose beads with prebound antibodies against Ssc1. After 2 h of 
gentle agitation at 4ºC, beads were washed 4 times with 500 l of IP buffer and bound 
proteins were eluted with 1 x Laemmli buffer and heating up at 95 °C for 5 min. Samples 
were analysed by SDS-PAGE and autoradiography. 
 
IP buffer 
20 mM TRIS-HCl pH 7.4,  
300 mM NaCl,  
0.2 % (v/v) Triton X-100,  
0.5 mM PMSF,  
1 x Complete Protease Inhibitor Cocktail (Roche) 
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3. Results 
3.1. Aggregation of the Ssc1 chaperone 
3.1.1. Ssc1 forms highly heterogeneous complexes in the absence of Hep1 
As previously reported, the mitochondrial Hsp70 chaperone Ssc1 has a tendency to 
aggregate (Sanjuan Szklarz et al. 2005; Sichting et al. 2005). In the absence of its 
chaperone Hep1, Ssc1 assembles irreversibly into oligomeric species of high molecular 
mass. Do these oligomeric species represent heterogeneous aggregates or homogenous 
complexes of distinct molecular mass? To test this, a sucrose gradient analysis was carried 
out. Mitochondria isolated from wild-type cells (wt) and cells lacking Hep1 (hep1) were 
solubilized in a Triton X-100-containing buffer and a short clarifying spin at 10000 x g 
was performed. Next, the extracts were separated on a continuous sucrose gradient. In the 
case of hep1 mitochondrial extract, a large portion of Ssc1 was found in the pellet 
fraction after the clarifying spin, indicating the presence of large molecular mass 
aggregates of Ssc1 (Fig. 3.1, right panel). The soluble portion of Ssc1 was detected in all 
fractions of the gradient. This reflects the presence of heterogeneous oligomeric Ssc1 
species of various sizes besides monomeric Ssc1 (Fig. 3.1, right panel). These species 
presumably represent intermediates in the aggregation process. In contrast, Ssc1 from the 
mitochondrial extracts of wild-type cells, as well as the control proteins from both 
mitochondrial extracts were detected in the top gradient fractions, indicating the presence 
of non-aggregated species (Fig. 3.1, left panel). 
In conclusion, Ssc1 tends to form heterogeneous, large aggregates of non-native Ssc1 
species in the absence of Hep1. 
Results 
 
 53
 
 
 
Figure 3.1. Separation of mitochondrial protein extracts from wild-type and 
hep1 cells by sucrose gradient centrifugation 
Mitochondrial extracts from wild-type (WT) and hep1 cells were subjected to a clarifying spin and 
soluble fractions were layered on a continuous sucrose gradient (10 % to 30 % of sucrose) and 
centrifuged for 40 min at 485,000 x g. The gradient was fractionated and the protein content of the 
fractions was analysed by SDS-PAGE and immunodecoration with the antibodies against the 
indicated proteins. Total (T), pellet (P) and the soluble fraction (load, L) after clarifying spin represent 
10 % of the material loaded onto the sucrose gradient. 
 
 
3.1.2. The ATPase domain with interdomain linker is responsible for 
aggregation of Ssc1 in the absence of Hep1 
In order to characterise the molecular mechanism of the aggregation of Ssc1 and its 
counteraction by Hep1, it was required to identify the structural determinants in Ssc1 that 
make it prone to aggregation. To this end, the individual domains of Ssc1 were expressed 
as his-tagged variants in the wild-type yeast strain and in hep1 strain and tested for 
solubility. In contrast to the full-length Ssc1, neither ATPase domain alone, nor PBD with 
the interdomain linker at its N-terminus, hence further referred to as PBD, was present in 
the fraction of aggregated material in the hep1 strain (Fig. 3.2a). These observations are 
consistent with the results obtained previously by M. Sichting (Sichting 2007). Apparently, 
neither the ATPase domain nor the PBD has the tendency to form aggregates. It could be 
the interdomain communication that triggers the formation of the aggregation-prone 
conformation in Ssc1. Since the interdomain linker is known to mediate the interdomain 
communication within Ssc1 via the interaction with the ATPase domain, a variant 
consisting of the ATPase domain with the interdomain linker (ATPaseLinker) was tested 
for aggregation. This variant was found to be soluble in wild-type mitochondria, but it was 
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partially present in the pellet fraction upon expression in the hep1 strain (Fig. 3.2b). 
These findings suggest that the ATPase domain together with the interdomain linker is 
responsible for the tendency of Ssc1 to aggregate. The specific amino-acid residues VLLL 
of the interdomain linker are critical for Ssc1 aggregation, since the ATPaseLinkerA4 
variant, in which the linker amino-acid residues were replaced by 4 alanine residues, was 
soluble in the presence and absence of Hep1 (Fig. 3.2b). Taken together, the ATPase 
domain of Ssc1 in combination with the interdomain linker adopts an aggregation-prone 
conformation, which leads to the formation of Ssc1 aggregates in the absence of Hep1. 
 
 
 
 
Figure 3.2. The ATPaseLinker aggregates in the absence of Hep1 
(a) Mitochondria from hep1 strains expressing his-tagged versions of ATPase domain, PBD or  
full-length Ssc1 were solubilized. Soluble (SN) and aggregated (P) proteins were separated by 
centrifugation. These fractions as well as total material (T) were subjected to SDS-PAGE and 
immunodecoration with antibodies against Ssc1. (b) Mitochondria from the hep1 and the wild-type 
(WT) strains expressing his-tagged variants of the ATPaseLinker and the ATPaseLinkerA4 were 
solubilized. Aggregation of the protein variants was assayed as described in (a). 
 
 
3.1.3. The ATPase domain with interdomain linker is the smallest entity  
within Ssc1 that interacts with Hep1 
To investigate the mechanism of the protective function of Hep1, the interaction 
between Hep1 and Ssc1 was analysed. Previous results by M. Sichting demonstrated that 
the ATPase domain in the context of a full-length Ssc1 is required for the interaction with 
Hep1 (Sichting et al. 2005; Sichting 2007). To find out whether the ATPase domain alone 
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is sufficient for this interaction, the full-length Ssc1, as well as its individual domains 
containing C-terminal his-tags, were analysed for the interaction with Hep1 by NiNTA 
pull-down. Since Ssc1 was reported to interact with Hep1 upon ATP depletion, isolated 
mitochondria expressing the aforementioned variants were depleted of ATP, solubilized 
and incubated with NiNTA beads. Non-bound and bound protein fractions were analysed 
by SDS-PAGE and immunodecoration. Hep1 was co-purified with the full-length Ssc1, 
however, it was not found in the bound fraction neither with the ATPase domain nor with 
the PBD (Fig. 3.3 upper panel). Apparently, the ATPase domain alone is necessary but not 
sufficient to interact with Hep1. Since the presence of the interdomain linker triggered the 
aggregation of ATPase domain in the absence of Hep1, it was expected that the ATPase 
domain together with the interdomain linker would be able to interact with Hep1. To test 
this hypothesis, an interaction of the ATPaseLinker variant with Hep1 upon depletion of 
ATP in wild-type mitochondria was analysed by the NiNTA pull-down. Indeed, Hep1 was 
found in the bound fraction together with the ATPaseLinker, indicating that it associates 
with the ATPaseLinker in organello (Fig. 3.3 lower panel). This interaction was specific, 
as Hep1 did not bind to the NiNTA beads when a non-his-tagged ATPaseLinker variant 
was used. Moreover, the interaction depended on the specific sequence of the interdomain 
linker, since Hep1 did not associate with the ATPaseLinkerA4 variant (Fig. 3.3 lower 
panel). Thus, the ATPase domain with the interdomain linker is necessary and sufficient 
for the interaction of Ssc1 with Hep1. 
 
 
 
 
Figure 3.3. Hep1 interacts with  
the ATPaseLinker 
Mitochondrial extracts from strains 
expressing the indicated Ssc1 variants with 
his-tags (unless otherwise stated) were 
depleted of ATP and subjected to the pull-
down assay with NiNTA beads. T, total (20 
%), FT, non-bound material (20 %) and B, 
bound fraction (100 %) were analysed by 
SDS-PAGE and immunodecoration with 
antibodies against Ssc1 and Hep1.  
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To corroborate these findings, a chemical crosslinking of mitochondrial proteins with 
DSG upon depletion of ATP was performed as described before (Sichting et al. 2005). 
Samples were analysed by SDS-PAGE and immunodecoration with -Hep1 antibodies. As 
expected, a crosslinked adduct of full-length Ssc1 and Hep1 was observed in all 
crosslinking agent-treated samples (Fig. 3.4a). However, when the ATPaseLinker variant 
was tested, an additional adduct corresponding from its size to the ATPase domain with the 
interdomain linker crosslinked to Hep1 was detected. This adduct bound to the NiNTA 
beads in the pull-down assay, confirming that the adduct indeed contained the his-tagged 
ATPaseLinker beside Hep1 (Fig. 3.4b). 
 
 
 
 
Figure 3.4. The ATPaseLinker forms a crosslinked adduct with Hep1 
(a) Mitochondria from strains expressing the indicated Ssc1 variants were depleted of ATP and 
subjected to chemical crosslinking with DSG. Samples were analysed by SDS-PAGE and 
immunodecoration with antibodies against Hep1. (b) Mitochondria were subjected to crosslinking as 
in (a), then they were solubilized and incubated with NiNTA beads. Non-treated control samples (-
DSG, 5 %), and DSG-treated samples (total, T (5 %), non-bound material, FT (5 %) and bound 
proteins, B (100 %)) were analysed by SDS-PAGE and immunodecoration with antibodies against 
Hep1. The adduct of Ssc1 and Hep1, as well as the adduct of the ATPaseLinker and Hep1, is depicted. 
The asterisk indicates a cross-reaction of the antibodies. 
 
 
Taken together, the ATPase domain in combination with the interdomain linker forms 
the smallest entity of Ssc1 that is recognized by Hep1. In the absence of Hep1, this entity 
has the tendency to aggregate and is responsible for aggregation of the full-length Ssc1. 
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3.2. De novo folding of the Ssc1 chaperone in organello  
and in vivo 
3.2.1. Ssc1 and the individual Ssc1 domains fold rapidly in organello 
To characterise the de novo folding of Ssc1, a folding assay based on the in vitro 
import of radiolabelled precursor into isolated mitochondria was established. In this assay, 
the folding state of the imported Ssc1 is assessed by trypsin treatment upon solubilization 
of mitochondria, since folded Ssc1 is trypsin-resistant, whereas the non-folded species are 
degraded. Ssc1 was rapidly imported into mitochondria, and almost all imported material 
was resistant to trypsin, indicating that the imported Ssc1 became folded (Fig. 3.5a). The 
kinetics of both import and folding of Ssc1 were comparable, demonstrating that the 
imported Ssc1 folds rapidly in organello (Fig. 3.5b).  
 
 
 
Figure 3.5. The chaperone Ssc1 folds rapidly in organello 
Radiolabelled Ssc1 precursor was imported into wild-type mitochondria for the indicated time 
periods. Non-imported material was digested with trypsin. Mitochondria were re-isolated and 
solubilized. Half of each sample was mock treated (-) to assess the import efficiency, the other half 
was digested with trypsin (+) to assess the folding state of the imported Ssc1. Samples were analysed 
by SDS-PAGE and autoradiography (a) and quantification (b). The amount of Ssc1 imported at the 
latest time point was set to 100 %. The graph shows mean values of five independent experiments  
+/- standard deviation. 
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3.2.2. The ATPase domain, in contrast to the PBD, requires the interdomain 
linker for folding 
To investigate the folding mechanism of Ssc1, the de novo folding of the individual 
Ssc1 domains in the context of the full-length protein was tested. To this end, constructs of 
the peptide binding domain (PBD) and the ATPase domain fused to the mouse 
dihydrofolate reductase (DHFR), from now on referred to as PBD-DHFR and ATPase-
DHFR, respectively, were generated. To exclude steric hindrance, the domains and DHFR 
were separated by a spacer of 80 amino acid residues (residues 87–167) of the yeast 
cytochrome b2 (Fig. 3.6).  
 
 
 
 
Figure 3.6. Schematic view of the Ssc1 variants used in the folding assay  
To analyse the folding of Ssc1, the depicted variants of Ssc1 were generated, in which the individual 
Ssc1 domains were fused to mouse DHFR via a spacer (residues 87–167 of cytochrome b2), to mimic 
the double domain organisation of the full-length protein. 
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The variants were imported into mitochondria and their folding state was assessed by 
trypsin digestion. The digestion of PBD-DHFR generated two protease-resistant fragments, 
corresponding in size to the folded PBD and DHFR (Fig. 3.7a). The kinetics of import and 
folding of the PBD-DHFR variant were virtually identical, indicating that the folding of 
this protein occurs immediately after it reaches the mitochondrial matrix. Notably, 
digestion of the imported ATPase-DHFR variant revealed only one protease-resistant 
fragment corresponding to the folded DHFR, whereas almost all of the ATPase domain 
molecules were trypsin-sensitive (Fig. 3.7b). This shows that the ATPase domain cannot 
fold in the context of the fusion protein. In contrast, the PBD folds rapidly, independently 
of the protein context. 
 
 
 
 
Figure 3.7. The PBD, but not the ATPase domain, folds in the context  
of the fusion protein 
Radiolabelled precursors of PBD-DHFR (a) and ATPase-DHFR (b) were imported into wild-type 
mitochondria. To asses the import efficiency and folding state of the variants, samples were treated as 
described in Fig. 3.5 and analysed by SDS-PAGE and autoradiography. The asterisk indicates the 
folded DHFR domain with non-digested spacer. 
 
 
Since the interdomain linker of Ssc1 interacts with the ATPase domain and induces 
conformational changes in this domain, we asked whether the interdomain linker has an 
effect on the folding of the ATPase domain. To this end, a radiolabelled ATPaseLinker-
DHFR variant was synthesized and its folding upon import into mitochondria was 
followed. As a control, an ATPaseA4-DHFR variant in which the linker amino-acid 
residues VLLL were changed to four alanine residues, was tested (Fig. 3.6). Interestingly, 
Results 
 
 60
compared to the ATPase-DHFR variant, the trypsin digestion of the ATPaseLinker-DHFR 
led to the appearance of an additional protease-resistant fragment corresponding to the 
folded ATPase domain (Fig. 3.8a). In contrast, in the case of the ATPaseA4-DHFR, only 
the DHFR domain folded (Fig. 3.8b). This implies that the de novo folding of the ATPase 
domain depends on the presence of the interdomain linker. 
 
 
  
Figure 3.8. Folding of the ATPase domain relies on the interdomain linker 
Radiolabelled precursors of ATPaseLinker-DHFR (a) and ATPaseA4-DHFR (b) were imported into 
wild-type mitochondria. When indicated, samples were treated with trypsin as described in Fig. 3.5 
and analysed by SDS-PAGE and autoradiography. The asterisk indicates the folded DHFR domain 
with non-digested spacer. 
 
 
To confirm the importance of the interdomain linker for the ATPase domain folding in 
the context of the full-length Ssc1 protein, the de novo folding of the Ssc1A4 mutant, in 
which the linker amino-acid residues were changed to four alanine residues, was tested. 
Trypsin treatment of the imported Ssc1A4 mutant generated a 35 kDa stable fragment, 
corresponding in size to the PBD (Fig. 3.9, left panel). An immunoprecipitation experiment 
with antibodies recognizing specifically either ATPase domain (ATPase) or the C-
terminus (Cterm) of Ssc1, confirmed that the fragment was the PBD (Fig. 3.9, right 
panel). This means that upon the mutation of the interdomain linker, the ATPase domain 
cannot fold properly, in contrast to the PBD, which folds independently of the linker. 
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Figure 3.9. Folding of the ATPase domain of the Ssc1A4 linker mutant  
is impaired 
Radiolabelled precursor of the Ssc1A4 linker mutant was imported into wild-type mitochondria for 
the indicated time periods. To asses the folding state of the variant, samples were treated as described 
in Fig. 3.5 and analysed by SDS-PAGE and autoradiography (left panel). Imported material as well as 
the stable trypsin-resistant fragment were subjected to immunoprecipitation with antibodies against 
full-length Ssc1 (Ssc1), ATPase domain (ATPase), C-terminus of Ssc1 (Cpep) and with pre-
immune IgGs (PI). Total material (T, 10 %) subjected to immunoprecipitation and the precipitated 
material were analysed by SDS-PAGE and autoradiography (right panel). 
 
 
Taken together, the data indicate that both domains of Ssc1 are independent folding 
units. The ATPase domain requires the interdomain linker for the correct folding, whereas 
the PBD folds irrespectively of the presence of the interdomain linker. 
 
3.2.3. Hep1 is required for the folding of the ATPase domain of Ssc1  
in organello 
In the section 3.1 it was shown that the chaperone Hep1 binds the aggregation-prone 
conformer of Ssc1 and thus prevents the formation of non-native Ssc1 oligomers. Is Hep1 
also required to assist the de novo folding of Ssc1 upon import of Ssc1 into mitochondria? 
To answer this question, the folding of the radiolabelled Ssc1 in mitochondria lacking 
Hep1 was tested. In contrast to the wild-type mitochondria (wt), only a 35 kDa stable 
fragment, but no full-length protein was observed upon trypsin digestion (Fig. 3.10, left 
panel). This indicates that folding of Ssc1 is impaired in the absence of Hep1. The stable 
fragment could be immunoprecipitated with antibodies recognizing specifically the C-
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terminus of Ssc1, demonstrating that it corresponds to the PBD (Fig. 3.10, right panel). 
This implies that in the absence of Hep1, the PBD of Ssc1 is able to fold, whereas the 
ATPase domain displays a folding defect. 
 
 
 
 
Figure 3.10. The folding of Ssc1 is impaired in the absence of Hep1 in organello 
Radiolabelled Ssc1 precursor was imported into hep1 and wild-type (wt) mitochondria for 30 min. 
The import was stopped by addition of valinomycin, samples were further incubated for the indicated 
time periods and treated as described in Fig. 3.5 to assess the folding state of Ssc1 (left panel). 
Imported Ssc1, as well as the stable fragment present in the lysates of hep1 mitochondria was 
subjected to immunoprecipitation with antibodies against full-length Ssc1 (Ssc1), the ATPase 
domain (ATPase), the C-terminus of Ssc1 (Cpep) and with pre-immune IgGs (PI). Total material 
(T, 10 %) subjected to immunoprecipitation and the precipitated material were analysed by SDS-
PAGE and autoradiography (right panel). 
 
 
To confirm these findings, the folding of the individual Ssc1 domains in hep1 
mitochondria using ATPaseLinker-DHFR and PBD-DHFR variants was assessed. Both 
variants were able to fold in the wild-type mitochondria. Moreover, folding of the DHFR 
in both variants was not affected by the lack of Hep1 (Fig. 3.11). However, in the absence 
of Hep1, only the PBD became trypsin-resistant (Fig. 3.11b), whereas almost all of the 
ATPase domain molecules were trypsin-sensitive (Fig. 3.11a). Thus, in the absence of 
Hep1, folding of the ATPase domain even in the context of the interdomain linker was 
impaired, in contrast to the folding of the PBD, which did not require Hep1. 
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Figure 3.11. The ATPase domain requires Hep1 for folding, whereas the PBD 
folds without Hep1 
Radiolabelled ATPaseLinker-DHFR (a) and PBD-DHFR (b) precursors were imported into hep1 
and wild-type (wt) mitochondria for 15 min. Import was stopped by addition of valinomycin, samples 
were further incubated for the indicated time periods and treated as described in Fig. 3.5. Samples 
were analysed by SDS-PAGE and autoradiography. Asterisks indicate folded DHFR domain with 
non-digested spacer. 
 
 
Taken together, these results clearly demonstrate that the chaperone Hep1 is crucial 
for the de novo folding of the Ssc1 in organello. Hep1 mediates the folding of the ATPase 
domain in the presence of the interdomain linker. 
 
3.2.4. The folding defect of Ssc1 is a direct consequence of the absence of Hep1 
in organello 
Deletion of the HEP1 gene has severe consequences for the correct functioning of 
yeast cells and it affects several cellular processes and features due to aggregation of 
mitochondrial Hsp70 proteins (Burri et al. 2004; Sanjuan Szklarz et al. 2005; Sichting et al. 
2005; Yamamoto et al. 2005). To check whether the observed folding defect of newly 
imported Ssc1 in hep1 mitochondria is not a secondary effect of the accumulation of non-
functional, aggregated Ssc1 in mitochondria, de novo folding of Ssc1 was tested in 
mitochondria from cells grown at different temperatures and displaying different 
phenotypic features. At low temperature (16 °C), a growth defect of hep1 cells and 
aggregation of Ssc1 was not observed (Fig. 3.12a, left panel), therefore mitochondria from 
those cells presumably did not accumulate strong secondary effects. On the other hand, 
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hep1 cells grown at 30 °C displayed a severe growth phenotype, and a significant fraction 
of Ssc1 aggregated (Fig. 3.12a, right panel). Moreover, an impairment of the import of 
Ssc1 into hep1 mitochondria from cells grown at 30 °C was observed, in consistence with 
previous reports (Sanjuan Szklarz et al. 2005; Sichting et al. 2005; Yamamoto et al. 2005). 
In contrast, no import defect was detected in hep1 mitochondria from cells grown at 16 
°C. However, a severe folding defect of imported Ssc1 was observed in both types of 
isolated mitochondria lacking Hep1, independently of the conditions of the cell growth 
(Fig. 3.12b). This strongly suggests that the observed folding defect of Ssc1 in organello is 
not a secondary effect of non-functional Ssc1 accumulated in the mitochondria lacking 
Hep1, but a direct consequence of the lack of Hep1. Apparently, Hep1 is required for the 
de novo folding of newly imported Ssc1. 
 
 
 
Figure 3.12. Folding defect of Ssc1 in hep1 mitochondria is not a secondary 
effect of the loss of Ssc1 function 
(a) Mitochondria from hep1 and wild-type (wt) strains grown at the indicated temperatures were 
solubilized; soluble (SN) and aggregated (P) proteins were separated by centrifugation. These 
fractions and total material (T, 100 %) were analysed by SDS-PAGE and immunodecoration with 
antibodies against Ssc1. (b) Radiolabelled Ssc1 precursor was imported for 30 min into mitochondria 
from hep1 and wild-type (wt) strains grown at the indicated temperatures. Next, import was stopped 
by valinomycin and samples were further incubated for the indicated time periods and treated as 
described in Fig. 3.5 to assess the folding state of imported Ssc1. Samples were analysed by SDS-
PAGE and autoradiography.  
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3.2.5.  Folding of Ssc1 is independent of the Hsp60, the Hsp78 and the mtHsp70 
chaperone system 
There are several chaperone systems residing in the mitochondrial matrix, which are 
involved in protein folding. The mitochondrial chaperonin Hsp60 together with the 
chaperone Hsp10, as well as the mitochondrial Hsp70 chaperone system promotes the 
folding of various substrates in vivo and in vitro. The Hsp78 chaperone, a member of the 
Clp/Hsp100 family was reported to closely cooperate with the mtHsp70 chaperone system 
and play a role for protein reactivation upon heat stress. Do these mitochondrial chaperone 
systems assist in the de novo folding of Ssc1? To answer this question, the folding of Ssc1 
in the mitochondria of the temperature-sensitive or deletion strains of these chaperones was 
tested. In the mitochondria of the mif4 strain, containing a temperature-sensitive lethal 
mutation in the HSP60 gene, Ssc1 folded with kinetics comparable to the folding in the 
wild-type mitochondria (Fig. 3.13a, left panel). In this strain, Hsp60 could not assemble 
into the functional homo-oligomeric complexes upon the shift to the non-permissive 
temperature and aggregated as previously shown (Fig. 3.13a, right panel) (Cheng et al. 
1990). Moreover, Ssc1 folded properly with comparable kinetics in the presence and 
absence of Hsp78 (Fig. 3.13b). This indicates that folding of Ssc1 is independent of Hsp60 
and Hsp78 chaperones. We also tested the mtHsp70 chaperone system itself, by using the 
strain lacking the J co-chaperone Mdj1. In the absence of Mdj1, the folding of Ssc1 was 
also not affected (Fig. 3.13c). This implies that the folding of Ssc1 does not require the 
mtHsp70 chaperone system.  
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Figure 3.13. Defects in mitochondrial chaperone systems do not affect folding  
of Ssc1  
Radiolabelled Ssc1 precursor was imported into mitochondria isolated from (a, left panel) mif4, (b) 
hsp78 and (c) mdj1 cells as well as from the corresponding wild-type (wt) cells for the indicated 
time periods. Samples were treated as described in Fig. 3.5 to assess the folding state of Ssc1 and 
analysed by SDS-PAGE and autoradiography. (a, right panel) Cells from mif4 and the corresponding 
wild-type strain were grown at 24 °C and then shifted to 37 °C, when indicated, and grown further for 
2.5 h. Then, cells were collected, disrupted with glass beads and solubilized with 1 % Triton X-100. 
Soluble (S) and aggregated (P) protein fractions were separated by centrifugation. These fractions 
were analysed by SDS-PAGE and immunodecoration with antibodies against bacterial GroEL, 
recognizing yeast Hsp60. Asterisks indicate cross-reaction of the antibodies. 
 
 
Similarly, no folding defects were observed when the folding of the ATPaseLinker-
DHFR variant was tested in all of the above-mentioned stains (Fig. 3.14). This implies that 
the folding of the ATPase domain is not affected in the absence of the functional 
chaperone systems of Hsp60, Hsp78 and mtHsp70. 
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Figure 3.14. Defects in mito- 
chondrial chaperone systems  
do not compromise folding  
of the ATPase domain with the 
interdomain linker 
Radiolabelled ATPaseLinker-DHFR pre- 
cursor was imported into mitochondria 
isolated from (a) mif4, (b) hsp78 and 
(c) mdj1 cells as well as from the 
corresponding wild-type (wt) cells for 
the indicated time periods. Samples were 
treated as described in Fig. 3.5 to assess 
the folding state of the imported variant 
and analysed by SDS-PAGE and 
autoradiography. 
 
 
In summary, none of the tested mitochondrial chaperone systems seemed to be 
involved in the de novo folding of the Ssc1 chaperone in organello. This suggests that 
Hep1 is the main helper protein required for the biogenesis of Ssc1. 
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3.2.6. Hep1 is required for de novo folding of Ssc1 in vivo 
To address, whether Ssc1 has a folding defect in the absence of Hep1 in vivo, an in 
vivo pulse-chase experiment, which allowed following the biogenesis of newly synthesized 
radiolabelled proteins in intact yeast cells, was performed. To this end, wild-type and 
hep1 cells were grown for 10 min in the presence of radioactive methionine to synthesize 
radiolabelled proteins (pulse). Next, protein synthesis was stopped, and an excess of cold 
methionine was added (chase). Mitochondria isolation, solubilization and trypsin digestion 
followed by an immunoprecipitation with anti-Ssc1 antibodies allowed the specific 
detection of the Ssc1 protein and its folding state. In hep1 and wild-type cells, the 
labelling efficiency and the mitochondrial import rates were comparable, since similar 
amounts of radiolabelled Ssc1 were precipitated from both mitochondrial extracts (Fig. 
3.15, - Trypsin). However, in wild-type mitochondria the majority of Ssc1 was trypsin-
resistant, thus folded. On the contrary, in hep1 mitochondria only a minor fraction of 
Ssc1 was trypsin-resistant and a stable fragment corresponding to the PBD was generated 
(Fig. 3.15). A chase of 20 min did not increase the amount of trypsin-resistant Ssc1 in 
mitochondria lacking Hep1. These results indicate a severe impairment of de novo folding 
of Ssc1 in the absence of Hep1 in vivo. Therefore, consistent with the findings in 
organello, the chaperone Hep1 mediates the de novo folding process of Ssc1 in vivo. 
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Figure 3.15. Folding of Ssc1 in vivo requires Hep1 
hep1 and wild-type cells (wt) were radiolabelled with 35S-methionine and chased with cold 
methionine for the indicated time periods after the protein synthesis was stopped. Mitochondria were 
then isolated, solubilized and mock-treated or treated with trypsin to assess the folding of proteins. 
Ssc1 was immunoprecipitated with antibodies against Ssc1 and samples were analysed by SDS-PAGE 
and autoradiography (left panel) and quantified by densitometry (right panel). Total material (- 
Trypsin) was set to 100 % for each time period, trypsin-resistant material is shown as percentage of 
total material. 
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3.3. Reconstitution of the de novo folding of the Ssc1 chaperone  
in vitro 
3.3.1.  Hep1 and ATP are crucial for the refolding of Ssc1 in the reconstituted  
in vitro system 
To dissect the molecular mechanism of Ssc1 folding and characterise the function of 
Hep1 in this process, an attempt was made to reconstitute the de novo folding of Ssc1 
using the purified components. To this end, mature Ssc1 and N-terminally his-tagged 
mature Hep1 were expressed as recombinant proteins and purified from bacterial cells (Fig 
3.16).  
 
 
 
 
Figure 3.16. Purified recombinant proteins used in this 
study 
Purified Ssc1, ATPaseLinker as well as his-tagged PBD, Mge1 and Hep1 
(5 mg each) were analysed by SDS-PAGE and Coomassie staining. 
 
 
The stability of the purified Ssc1 was tested by trypsin treatment using a broad range 
of trypsin concentrations. Purified Ssc1 was apparently not susceptible to trypsin, which 
implies that the purification yielded a stable, correctly folded protein (Fig. 3.17). 
 
 
 
 
Figure 3.17. Purified recombinant Ssc1 is trypsin-
resistant 
Purified Ssc1 (6 mg) was treated with various concentrations of trypsin 
to assess the stability. Samples were analysed by SDS-PAGE and 
Coomassie staining. 
 
 
To reconstitute the folding process of Ssc1, purified Ssc1 was denatured by 
precipitation and resuspension in buffer with 8 M urea and subsequently diluted in the 
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refolding buffer containing recombinant Hep1 and/or ATP. Refolding of Ssc1 was 
monitored by trypsin resistance. Only in the presence of ATP and equimolar amounts of 
Hep1, Ssc1 became resistant to trypsin. On the contrary, no or minor amounts of trypsin-
resistant full-length Ssc1 were detected, when Hep1 or ATP were missing in the refolding 
buffer (Fig. 3.18). In summary, denatured Ssc1 can be efficiently refolded in an in vitro 
system. Hep1 and ATP are crucial for the refolding process.  
 
 
 
 
Figure 3.18. Ssc1 requires Hep1 and ATP for its refolding in vitro 
Unfolded Ssc1 was diluted into refolding buffer with or without addition of recombinant Hep1 and/or 
ATP. At the indicated time points, samples were withdrawn and treated with trypsin. Samples were 
analysed by SDS-PAGE and Coomassie staining. Input, 100 % of protein added into the refolding 
reactions. 
 
 
Next, the folding kinetics of Ssc1 in the presence of ATP was analysed in the 
refolding buffer with and without recombinant Hep1. In the presence of Hep1, Ssc1 
became trypsin resistant in a few minutes (Fig. 3.19). Apart from full-length Ssc1, two 
fragments of 45 kDa and 35 kDa were observed upon trypsin treatment of the samples at 
the early time points of refolding (Fig. 3.18 and 3.19). These fragments presumably 
resulted from a digestion of a folding intermediate of Ssc1 and would correspond to the 
PBD and ATPase domain, respectively. This implies that both Ssc1 domains fold and 
become trypsin-resistant individually, before the full-length Ssc1 acquires the final, fully 
protease-resistant conformation. In the absence of Hep1, only a 35 kDa fragment 
corresponding to the PBD was formed, indicating that the PBD was able to fold, in contrast 
to the ATPase domain. This suggests that the PBD can fold independently of Hep1, 
whereas the ATPase domain needs Hep1 for folding in vitro. 
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Figure 3.19. Kinetics of refolding of Ssc1 in vitro 
Unfolded Ssc1 was diluted into refolding buffer containing ATP in the presence (left panel) or 
absence (right panel) of recombinant Hep1. At the indicated time points, samples were withdrawn and 
half of each sample was treated with trypsin to assess folding, the other half was mock-treated. 
Samples were analysed by SDS-PAGE and Coomassie staining. 
 
3.3.2.  Denatured Ssc1 does not aggregate and retains its folding competence  
in the absence of Hep1 
In the absence of chaperones, unfolded or misfolded proteins have a tendency to 
acquire an off-pathway conformation and are not able to reach the native state. Such off-
pathway conformers have a high propensity to form aggregates. It was tested whether 
denatured Ssc1 is able to fold when it is first diluted from urea and incubated in the 
refolding buffer in the absence of Hep1 and ATP. To this end, denatured Ssc1 was diluted 
in the refolding buffer and pre-incubated for 30 min at 37 °C. Then, ATP and recombinant 
Hep1 were added and the sample was further incubated at 25 °C to allow refolding. As a 
control, denatured Ssc1 was diluted into the refolding buffer with ATP and Hep1 added 
directly prior to Ssc1 addition. Samples were withdrawn at the indicated time points and 
half of each sample was treated with trypsin to assess the folding state of Ssc1. All samples 
were subjected to a clarifying spin and analysed by SDS-PAGE and Coomassie staining. 
For the mock-treated samples, no loss of protein upon pre-incubation in the absence of 
Hep1 and ATP was observed, implying that no large Ssc1 aggregates that could be 
removed by the clarifying spin were formed (Fig. 3.20, left panel). Moreover, upon 
addition of ATP and Hep1 to the pre-incubated Ssc1, the protein became trypsin-resistant, 
comparable to the control sample (Fig. 3.20, right panel). This suggests that denatured 
Ssc1, upon dilution in the refolding buffer, does not aggregate and remains in a folding-
competent state in the absence of its folding helper.  
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Figure 3.20. Denatured Ssc1 remains folding-competent upon pre-incubation  
in the absence of Hep1 
Unfolded Ssc1 was diluted into refolding buffer and pre-incubated in the absence of recombinant 
Hep1 and ATP for 30 min at 37 °C. Then, ATP and Hep1 were added and the sample was further 
incubated at 25 °C to allow refolding. As a control, unfolded Ssc1 was directly incubated in the buffer 
containing ATP and Hep1 at 25 °C. Samples were withdrawn at the indicated time points and half of 
each sample was treated with trypsin (right panel) to assess the folding state of Ssc1. The other half 
was mock treated (left panel). Samples were analysed by SDS-PAGE and Coomassie staining. 
 
3.3.3.  Hep1 can be repeatedly used for refolding of Ssc1 
Equimolar amounts of Hep1 efficiently promote refolding of Ssc1. Does the rate of 
the refolding reaction depend on the molar ratio between Hep1 and denatured Ssc1? To test 
this, the folding assay at the molar ratios of 1:1, 1:0.5 and 1:0.25 of Ssc1 to Hep1 was 
performed and the kinetics of refolding over a period of 120 min was measured. Although 
the initial rates of refolding of Ssc1 decreased with the decreasing concentration of Hep1, 
the amount of refolded Ssc1 at the end of the incubation reached 80–100 % in each case 
(Fig. 3.21). This suggests that each Hep1 molecule is able to mediate several rounds of 
Ssc1 refolding. 
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Figure 3.21. Hep1 mediates several rounds of refolding of Ssc1 
Unfolded Ssc1 was diluted into refolding buffer containing ATP and recombinant Hep1 in molar 
ratios of 1:1, 1:0.5 and 1:0.25 of Ssc1 to Hep1. Samples were incubated at 25 °C to allow refolding, 
subsequently treated with trypsin and analysed by SDS-PAGE and Coomassie staining. The signals of 
trypsin protected full-length Ssc1 were quantified by densitometry. The signals of mock-treated 
samples of the longest time period (total) were set to 100 %. The graph shows mean values of 5 
independent experiments +/- standard deviation. 
 
3.3.4.  Ssc1 refolded in vitro in the presence of Hep1 is enzymatically active 
To prove that refolded Ssc1 is not only trypsin-resistant, but also enzymatically active, 
the ATPase activity of the refolded protein was measured. To this end, a coupled ATP-
regenerating enzymatic assay was performed with the native Ssc1 and with the denatured 
Ssc1 subjected to the refolding procedure in the absence and presence of Hep1. Whereas 
the denatured Ssc1 remained inactive in the absence of Hep1 (Fig. 3.22a, Control), Ssc1 
refolded in the presence of Hep1 regained almost 70 % of the activity as compared to the 
native protein (Fig. 3.22a). Similar results were obtained when a radioactive assay was 
used (Fig. 3.22b). Apparently, the protease-resistant conformation of Ssc1 that was 
adopted upon refolding in the presence of Hep1 represents the native and active form of 
Ssc1. 
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Figure 3.22. Refolded Ssc1 is enzymatically active 
Native and unfolded Ssc1 were incubated in ATP-containing buffer in the presence or absence of 
recombinant Hep1. Then the ATPase activities of the samples in the presence of the co-chaperones 
Mge1 and DnaJ were measured using the spectrophotometric enzymatic assay (a) and the radioactive 
assay (b). The ATPase activity of native Ssc1 (-Hep1) was set to 100 %. Control, unfolded Ssc1 
incubated in the absence of Hep1. Diagram (a) represents the mean values of three independent 
measurements +/- standard deviation. 
 
3.3.5. Adenine nucleotides promote the folding of Ssc1 in the presence of Hep1 
In section 3.3.1, it was demonstrated that ATP is required for the refolding of Ssc1 in 
vitro in the presence of Hep1 (Fig. 3.18). Do other adenine nucleotides promote the folding 
of Ssc1 as well? To address this, the refolding of Ssc1 in the presence of Hep1 with the 
addition of various adenine nucleotides, able to bind to the native Ssc1, was tested. 
Interestingly, both ATP and ADP promoted the folding of Ssc1 with a comparable 
efficiency. Addition of a non-hydrolyzable ATP analogue, ATPS, led to the folding of 
Ssc1 as well, albeit with slightly reduced efficiency. Virtually no trypsin-protected Ssc1 
was formed in the presence of another non-hydrolyzable ATP analogue, AMP-PNP, or in 
the absence of any nucleotide (Fig. 3.23). This means, that the presence of nucleotide is 
necessary for the refolding of Ssc1 in vitro, and other adenine nucleotides, in addition to 
ATP, promote the folding of Ssc1 in the presence of Hep1. Apparently, the hydrolysis of 
ATP is not required for the folding of Ssc1, since ADP and ATPS can replace ATP in the 
refolding process. Instead, it is the binding of nucleotides that triggers the formation of a 
folded protein.  
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Figure 3.23. Adenine nucleotides are required for the folding of Ssc1 in vitro 
Unfolded Ssc1 was incubated in refolding buffer containing recombinant Hep1 and the indicated 
nucleotides. After the indicated time periods, samples were withdrawn, treated with trypsin and 
analysed by SDS-PAGE and Coomassie staining. 
 
3.3.6. Individual domains of Ssc1 fold in vitro 
To analyse the requirements for the folding of the individual Ssc1 domains in the 
reconstituted system, mature non-tagged ATPaseLinker and C-terminally his-tagged PBD 
were expressed and purified from bacterial cells (Fig. 3.16) and subsequently denatured 
similarly to the purified Ssc1. Both proteins were diluted in the refolding buffer, incubated 
with and without Hep1 and ATP and their folding state was tested by trypsin digestion. 
The ATPaseLinker became trypsin-resistant only in the presence of both Hep1 and ATP 
(Fig. 3.24a). In contrast, the PBD was able to efficiently refold independently of Hep1 and 
ATP (Fig. 3.24b). These observations are consistent with the results obtained in organello 
and in vivo. It is apparently the ATPase domain in the full-length Ssc1 that requires Hep1 
and an adenine nucleotide for the de novo folding. On the contrary, the PBD folds 
spontaneously in the absence of folding helpers. 
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Figure 3.24. ATPaseLinker and PBD fold independently in vitro 
Unfolded ATPaseLinker (a) or PBD (b) were incubated in refolding buffer containing ATP and/or 
recombinant Hep1. After the indicated time periods, samples were withdrawn, treated with trypsin and 
analysed by SDS-PAGE and Coomassie staining. Input, 100 % of protein added to the refolding 
reactions. 
 
3.3.7.  Mge1 does not promote the folding of Ssc1 
Is the involvement in the refolding process of Ssc1 specific for Hep1? It was 
previously reported that another interaction partner of Ssc1 – the nucleotide exchange 
factor Mge1 – is able to keep Ssc1 soluble upon co-expression in E.coli (Momose et al. 
2007). Therefore, the refolding of Ssc1 was tested in the presence of recombinant Mge1. 
Even a four-fold molar excess of Mge1 over Ssc1 did not promote the folding of the full-
length Ssc1, nor of the ATPaseLinker (Fig. 3.25). Thus, the chaperone function in the 
folding of Ssc1 is most likely specific for Hep1 and cannot be taken over by other 
interaction partners of Ssc1 such as Mge1. 
 
 
 
Figure 3.25. Mge1 does not mediate refolding of Ssc1 in vitro 
Unfolded Ssc1 or ATPaseLinker were incubated in refolding buffer containing ATP and a four-fold 
molar excess of recombinant Mge1 or equimolar amount of recombinant Hep1 as a control. After the 
indicated time periods, samples were withdrawn, treated with trypsin and analysed by SDS-PAGE and 
Coomassie staining. Input, 100 % of protein added to the refolding reactions. 
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3.3.8. Hep1 interacts with a folding intermediate of Ssc1 
Since Hep1 is required for the de novo folding of Ssc1 in vitro, it presumably 
transiently interacts with the folding Ssc1. To trap this interaction, a chemical crosslinking 
experiment with glutaraldehyde was performed. To this end, denatured Ssc1 was incubated 
with or without Hep1 and ATP and then the crosslinking reagent was added. All samples 
were analysed by SDS-PAGE and Coomassie staining, as well as western-blotting and 
immunodecoration against Hep1 and Ssc1. In the presence of Hep1, a crosslinked adduct 
containing Ssc1 and Hep1 was observed on the Coomassie-stained gel and on the 
immunodecoration (Fig. 3.26, lanes 8, 9, 13, 14, 18, 19). The crosslinked adduct was 
formed in the absence of ATP. Moreover, addition of ATP almost completely abolished 
the adduct formation (Fig. 3.26, lanes 9, 14, 19). This implies that in the absence of ATP 
the interaction between Hep1 and the folding Ssc1 was trapped, whereas in the presence of 
ATP the folding process of Ssc1 was completed and thus, Hep1 did not interact with Ssc1 
anymore. In the presence of both Hep1 and ATP, a sharp band corresponding to the 
monomeric Ssc1 was observed on the Coomassie-stained gel and immunodecoration (Fig. 
3.26, lanes 9, 19), reflecting that Ssc1 was able to adopt a folded structure, not accessible 
to the crosslinking reagent. In contrast, the signals in the other lanes were more diffuse due 
to the unfolded state of Ssc1, which allowed extensive modifications and the formation of 
intramolecular bridges by the crosslinking reagent. In conclusion, binding of Hep1 to Ssc1 
is one of the early steps in the process of Ssc1 folding, and it precedes the nucleotide-
dependent step. 
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Figure 3.26. Hep1 interacts with folding Ssc1 in the absence of ATP 
Unfolded Ssc1 was diluted into refolding buffer containing Hep1 and/or ATP, where indicated. 
Samples were incubated at 30ºC for 20 min and then treated with or without the crosslinking reagent 
(glutaraldehyde). Samples were analysed by SDS-PAGE and Coomassie staining. Aliquots of the 
samples (15 %) were analysed by SDS-PAGE, western-blotting and immunodecoration with 
antibodies against Hep1 and Ssc1. 
 
3.3.9. Incubation with ATP after removal of Hep1 does not promote folding  
of Ssc1 
As shown in the previous section, Hep1 interacts with the folding intermediate of Ssc1 
prior to the adenine nucleotide. Is Hep1 released from the partially folded intermediate of 
Ssc1 before the nucleotide binds and triggers further folding? To test this, denatured Ssc1 
was incubated with Hep1 in the absence of nucleotides and subsequently a NiNTA pull-
down was performed to deplete the sample of Hep1 containing a his-tag. As a control, the 
same procedure was carried out in the absence of Hep1. Non-bound material from the pull-
down (FT) was then supplemented with ATP and, where indicated, freshly added Hep1, as 
a control, and the samples were further incubated to allow refolding of Ssc1. Half of each 
sample was treated with trypsin to asses the folding state of Ssc1 and all samples were 
analysed by SDS-PAGE and imunodecoration (Fig. 3.27a).  
Following the incubation of Ssc1 with Hep1, Hep1 efficiently bound to the NiNTA 
beads and was fully depleted from the sample (Fig. 3.27b, upper panel). In that sample, 
upon the addition of ATP, Ssc1 remained trypsin-sensitive, thus, it did not fold (Fig. 3.27b, 
lower panel, lane 1). However, Ssc1 remained able to fold in the course of the procedure, 
since it became folded upon the addition of the fresh portion of Hep1 (Fig. 3.27, lower 
panel, lane 2). Similar results were obtained with Ssc1 incubated in the absence of Hep1 
prior to the pull-down (Fig. 3.27b, lower panel, lanes 5 and 6). This means that Hep1 
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removal prior to the nucleotide addition, similarly to lack of Hep1, prevents folding of 
Ssc1. According to these findings, it is unlikely that Hep1 induces stable structural changes 
in the folding intermediate of Ssc1 and then dissociates from Ssc1 before the nucleotide-
dependent step in the folding process takes place. It is more likely that the nucleotide binds 
to the folding intermediate of Ssc1 that is associated with Hep1 and triggers further 
folding. 
Notably, only a small portion of Ssc1 was found in the fraction associated with the 
beads after pull-down of Hep1 (Fig. 3.27b, upper panel). This portion corresponded to the 
Ssc1 specifically bound to Hep1, since no Ssc1 was found in the bound fraction in the 
absence of Hep1. This suggests that under experimental conditions the interaction between 
the folding intermediate of Ssc1 and Hep1 is rather transient. Most probably, there is an 
equilibrium between free Ssc1 and Ssc1 transiently interacting with Hep1 in the absence of 
nucleotide. Removal of Hep1 shifts this equilibrium towards the folding intermediate of 
Ssc1 that is unable to fold further upon the addition of nucleotide. 
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Figure 3.27. Removal of Hep1 prior to the nucleotide addition prevents  
the folding of Ssc1 
(a) Scheme of the experimental procedure. (b) Unfolded Ssc1 was diluted into the buffer containing 
Hep1, where indicated. Samples were incubated at 30ºC for 30 min and then Hep1 was removed by 
NiNTA beads. An aliquot of non-bound material (FT, 20 %) was withdrawn and analysed, together 
with total (T, 20 %) and bound fraction (B, 100 %) by SDS PAGE and immunodecoration against 
Ssc1 and Hep1 (upper panel). The remaining non-bound material was supplemented with ATP and, 
where indicated, Hep1, and further incubated at 25 °C for 20 min to allow refolding of Ssc1. Half of 
each sample was treated with trypsin to assess the folding state of Ssc1 (+ Trypsin); the other half was 
mock-treated  
(- Trypsin) (lower panel). Samples were analysed by SDS-PAGE and immunodecoration with 
antibodies against Ssc1 
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3.3.10. Mge1 does not bind to the folding intermediate of Ssc1 
In section 3.3.7 it was shown that nucleotide exchange factor Mge1 is not able to 
mediate the folding of Ssc1 (Fig. 3.25). To test whether Mge1 can at all interact with the 
folding intermediate of Ssc1, a chemical crosslinking in the absence of ATP was carried 
out. As a control, Hep1 instead of Mge1 was used. Samples were analysed by SDS-PAGE, 
Coomassie staining and immunodecoration with antibodies against Hep1 and Mge1. In 
contrast to Hep1, Mge1 did not form a crosslinked adduct with denatured Ssc1 (Fig. 3.28, 
lanes 3 and 11). It also did not influenced the adduct formation between denatured Ssc1 
and Hep1, when all three proteins were incubated together (Fig. 3.28, lanes 4, 8, 12). This 
indicates that Mge1, unlike Hep1, is not able to recognize and bind to the folding 
intermediate of Ssc1, even though it interacts with the native Ssc1 under the same 
experimental conditions (data not shown). This lack of interaction between Mge1 and 
folding Ssc1 explains why Mge1 is not able to replace Hep1 during the folding process of 
Ssc1 in vitro.  
 
 
 
 
Figure 3.28. Mge1 does not interact with the folding Ssc1 
Unfolded Ssc1 was diluted into the buffer containing, where indicated, Mge1 and/or Hep1. Samples 
were incubated at 30ºC for 20 min and then treated with or without the crosslinking reagent 
(glutaraldehyde). Samples were analysed by SDS-PAGE and Coomassie staining. Aliquots of the 
samples (15 %) were analysed by SDS-PAGE and immunodecoration with antibodies against Hep1 
and Mge1. 
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3.3.11. Adenine nucleotides trigger release of Hep1 from the complex  
with the folding intermediate of Ssc1 
Since various adenine nucleotides affected the folding process differently (Fig. 3.23), 
the effects of those nucleotides on the formation of the crosslinked adduct between Ssc1 
and Hep1 were analysed by SDS-PAGE, Coomassie staining and immunodecoration 
against Hep1. In the presence of ATP, as well as ADP, no Ssc1-Hep1 adduct was observed 
(Fig. 3.29a, lanes 7, 8, 12, 13) and a distinct band corresponding to the folded monomeric 
Ssc1 was present on the Coomassie-stained gel (Fig. 3.29a, lanes 7 and 8). Addition of 
ATPS led to low amounts of adduct (Fig. 3.29a, lanes 9 and 14), whereas in the presence 
of AMP-PMP, the adduct formed very efficiently (Fig. 3.29a, lanes 10 and 15). Similar 
results were obtained, when Ssc1 and Hep1 were pre-incubated together to allow complex 
formation prior to the nucleotide addition (chase). The pre-formed complex (Fig. 3.29b, no 
chase) dissociated upon incubation with ATP or ADP. Upon addition of ATPS, a 
reduction in the amount of the complex was observed. No effect on the complex was 
observed when AMP-PNP was added (Fig. 3.29b). These findings further support the 
results from section 3.3.8, demonstrating that Hep1 binds to the folding Ssc1 prior to the 
nucleotides. Binding of Hep1 induces structural changes in the folding intermediate of 
Ssc1 that trigger recognition of various nucleotides. Nucleotide binding promotes further 
folding of Ssc1 to the final native state and release of Hep1. Not every nucleotide tested, 
however, triggered dissociation of Hep1 with the same efficiency. The observed variability 
may reflect diverse affinities of the nucleotides to the Hep1-bound folding intermediate of 
Ssc1. On the other hand, binding of various nucleotides might induce different structural 
changes in Ssc1 that affect the stability of the complex with Hep1 differently. 
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Figure 3.29. Nucleotides have various effects on the interaction of Hep1 with the 
folding intermediate of Ssc1 
(a) Unfolded Ssc1 was incubated for 20 min at 30ºC in the buffer containing, where indicated, Hep1 
and different nucleotides. Then, samples were treated with the crosslinking reagent (glutaraldehyde) 
and analysed by SDS-PAGE and Coomassie staining. Aliquots of the samples (15 %) were analysed 
by SDS-PAGE, western-blotting and immunodecoration with antibodies against Hep1. 
(b) Unfolded Ssc1 was incubated with Hep1 for 10 min at 30 °C (no chase). Then, nucleotides were 
added, where indicated, and samples were further incubated for 10 min. All samples were treated with 
glutaraldehyde and analysed by SDS-PAGE, western-blotting and immunodecoration with antibodies 
against Hep1. 
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4. Discussion 
4.1. Aggregation of the Ssc1 chaperone 
Yeast mitochondrial Hsp70 chaperone Ssc1 is an essential constituent of the import 
motor of the TIM23 translocase and one of the main folding helpers of the mitochondrial 
proteins, playing an indispensable role in the mitochondrial biogenesis. In order to fulfill 
its function, Ssc1 acquires a native structure that leads to the propensity of self-
aggregation. This propensity is counteracted by the presence of the escort protein Hep1, 
which is required to keep Ssc1 in a soluble and active state. 
The present study concentrated on the aggregation propensity of the Ssc1 chaperone in 
the absence of Hep1. It focused on the analysis of the nature of the Ssc1 aggregates as well 
as the structural determinants within Ssc1 that make it prone to aggregation. Moreover, this 
study characterised the smallest region within Ssc1 required for the interaction with Hep1. 
As shown, this region overlapped with the aggregation-prone region of Ssc1. 
A propensity to self-oligomerize was previously observed for other Hsp70 proteins. 
Human cytosolic Hsp70 and Hsc70 proteins were reported to form oligomers in a 
temperature- and ATP-dependent manner (Angelidis et al. 1999). Moreover, a similar 
ATP-dependent behavior was observed for the ER Hsp70 chaperone Grp78 (Carlino et al. 
1992) and for the bacterial DnaK (Thompson et al.; Schonfeld et al. 1995). Apart from 
ATP addition, the peptide substrates and, in the case of DnaK, co-chaperones were able to 
reverse the oligomerization process of those Hsp70 chaperones. This implies that the PBD 
was involved in the oligomerization process. In the case of Ssc1, the observed aggregation 
is irreversible, and it is not influenced by the addition of nucleotides and substrates 
(Sichting et al. 2005). Moreover, the Ssc1 aggregates formed in vivo in the absence of 
Hep1 were presumably much larger then those reported for the other Hsp70 chaperones, 
since a fraction of them was removed by low speed centrifugation. The remaining soluble 
Ssc1 species did not form any defined oligomers, but highly heterogenous associates, 
corresponding most likely to intermediates in the aggregation process. In summary, a 
different mechanism seems to apply for the self-aggregation of Ssc1 than in the case of 
other Hsp70 proteins. 
Why does the mitochondrial Hsp70 chaperone behave differently from other Hsp70 
family members? Ssc1 is synthesized on cytosolic ribosomes and subsequently imported 
Discussion 
 
 86
into the mitochondrial matrix, where it has to fold de novo to acquire the native structure. 
Such a complicated biogenesis pathway might explain the aggregation propensity of this 
protein. However, bacterial DnaK, when expressed in yeast and directed to the 
mitochondria by a mitochondrial targeting signal, did not aggregate even in the absence of 
Hep1 (Blamowska et al. 2011). This implies that the import into mitochondria per se does 
not cause aggregation of mitochondrial Hsp70 proteins and that the aggregation propensity 
appears to be an intrinsic feature of the mitochondrial Hsp70 proteins. Mapa et al. (2010) 
showed that Ssc1 is much more flexible than bacterial DnaK. The binding of a substrate 
peptide induces additional conformational changes beside the changes induced by the 
nucleotide, particularly by the hydrolysis of ATP to ADP. Mapa et al. (2010) speculated 
that such behavior might reflect cross-talk between the Ssc1 and the translocase during the 
pre-protein import process. Therefore, such enhanced flexibility of Ssc1, required for its 
correct functioning in mitochondria, may result in the propensity to aggregate.  
Another distinct feature of the aggregation process of Ssc1, in contrast to the 
oligomerization of other Hsp70 class members, is the involvement of the ATPase domain, 
not the PBD. However, the ATPase alone does not aggregate in the absence of Hep1. It is 
the interdomain linker segment that renders the ATPase domain prone to aggregation. The 
interdomain linker segment alone is, however, also not responsible for the aggregation 
propensity, since the linker fused to the PBD did not cause aggregation of the PBD. 
Moreover, DnaK contains the interdomain linker of the same sequence as Ssc1 and it was 
still soluble in the absence of Hep1 (Blamowska et al. 2011). Apparently, both ATPase 
domain and the adjacent linker contribute to the aggregation propensity of Ssc1. Since an 
interaction of the linker with the ATPase domain and a crucial role of the linker in 
interdomain communication and ATPase stimulation was reported for DnaK (Vogel et al. 
2006; Swain et al. 2007), it is very likely that the linker binds to the ATPase domain and 
induces its aggregation-prone conformation in Ssc1. 
In the presence of Hep1, however, no aggregation of Ssc1 was observed. Hep1 was 
able to bind to the ATPase in the context of the interdomain linker segment, preventing 
aggregation. Since Hep1 does not interact with the PBD in combination with the linker 
segment, nor with the DnaK protein, it is the ATPase domain of Ssc1 with the adjacent 
linker segment that is necessary and sufficient to bind Hep1. These findings are consistent 
with the study of Zhai et al. (2008), showing that the ATPase domain of the human 
mtHsp70 interacts with the human HEP protein. The ATPase construct used by Zhai et al 
consists in fact of the ATPase domain and the interdomain linker. Since the ATPase 
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domain together with the interdomain linker acquires the aggregation-prone conformation 
within Ssc1, recognition of that aggregation-prone region by Hep1 reflects the anti-
aggregation function of Hep1 on Ssc1. 
Based on these findings, one can suggest a model of Hep1 action (Fig. 4.1). During 
the reaction cycle of the native Ssc1 in mitochondria, the ATPase domain in the context of 
the linker segment may adopt an aggregation-prone conformation. This conformation is 
likely to occur in the nucleotide-free state of Ssc1. In the absence of Hep1, the formation 
and accumulation of aggregation-prone conformers leads to their association in large non-
functional aggregates. However, if Hep1 is present, it recognizes those conformers and 
binds to the ATPase domain and the linker, thus hindering aggregation and allowing Ssc1 
to adopt the native conformation again.  
The aggregation-prone conformer could also possibly be formed by Ssc1 during the de 
novo folding of newly synthesized Ssc1 imported into mitochondria. This possibility and 
therefore the involvement of Hep1 in the folding process of Ssc1 are discussed later. 
 
 
 
Figure 4.1. Model of anti-aggregating action of Hep1. See text for details. 
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The exact mechanism through which Hep1 escorts Ssc1 to the native state remains 
unclear. Presumably, Hep1 functions as a holdase and passively prevents Ssc1 aggregation 
by reducing the concentration of the free aggregation-prone species by kinetic partitioning. 
Alternatively, binding of Hep1 to the non-native conformers induces certain 
conformational changes within Ssc1 and stabilizes the native state of the chaperone. The 
release of Hep1 from Ssc1 may be achieved in a nucleotide-dependent manner, as it was 
reported that Ssc1 interacts with Hep1 upon ATP depletion (Sichting et al. 2005). Thus, 
binding of ATP to the ‘rescued’ Ssc1 molecule may result in dissociation of Hep1. 
The formation of the aggregation-prone conformers by Ssc1 is likely not to occur too 
often, since the concentration of Hep1 molecules in mitochondria is much lower than the 
concentration of the very abundant Ssc1 chaperone (Sichting et al. 2005). Moreover, even 
minor amounts of Hep1 protein were sufficient to keep Ssc1 in a functional form, since no 
growth phenotype was observed upon down-regulation of Hep1 expression in yeast, in 
contrast to the HEP1 deletion strain (unpublished results of M. Sichting, personal 
communication). In complete absence of Hep1, non-native aggregation-prone Ssc1 species 
accumulate with time. 
Although the function of Hep1 in the prevention of aggregation of Ssc1 is well-
documented, the mechanistic insights into this process are still missing. It would be 
interesting to study in detail the interaction between those two chaperones and unravel the 
mechanism through which this interaction is regulated under cellular conditions. 
 
 
4.2. De novo folding of the Ssc1 chaperone 
Due to their involvement in protein folding, assembly and degradation, molecular 
chaperones play an indispensable role in cellular proteostasis. Multiple functions of 
molecular chaperones in protein biogenesis have been extensively studied and 
characterised. In contrast, the biogenesis of chaperones has barely been described. 
Particularly, the folding of Hsp70 chaperones, the main protein folding helpers in the cell, 
has been poorly characterised to date. 
The present study reports on the novel approaches to analyse the biogenesis of the 
yeast mitochondrial Hsp70 chaperone Ssc1 and on the exciting results obtained. First, the 
de novo folding of Ssc1 upon import into isolated mitochondria was followed and 
characterised. Second, the folding defect of Ssc1 in the absence of the helper protein Hep1 
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was described using in organello and in vivo studies. Hep1 and none of the general 
chaperone systems tested were found to be crucial for the correct folding of Ssc1, in 
particular for the ATPase domain of Ssc1. Third, the folding process of Ssc1 was 
reconstituted in vitro using purified components, and the main steps of the folding pathway 
of Ssc1 were dissected. Hep1 and ATP/ADP were found to be the only components, 
necessary and sufficient for the efficient folding of Ssc1 into the enzymatically active 
form.  
In order to follow the folding process of Ssc1 and to distinguish between folded and 
unfolded Ssc1, a fast and precise assay based on trypsin resistance of the native Ssc1 was 
established. This assay was successfully used in organello and in vivo as well as in a 
modified form in vitro. To prove that the trypsin-resistant form of Ssc1 corresponds to the 
native and catalytically active conformation of the protein, the ATPase activity of the 
purified native and refolded Ssc1 was measured. Indeed, Ssc1 species that had refolded in 
a reconstituted system to the trypsin-resistant form regained their enzymatic activity, 
whereas the trypsin-sensitive Ssc1 species remained inactive. This implies that the trypsin-
resistant Ssc1 species represent the native and folded protein, which validates the trypsin 
resistance-based approach used throughout the present study. The trypsin assay used in 
organello and in vivo allowed the identification of a severe folding defect of newly 
imported Ssc1 in hep1 mitochondria. This finding was further corroborated in the 
reconstituted system, showing the crucial role of Hep1 in the folding process of Ssc1. 
To date, the folding of chaperones was assumed to happen either spontaneously, or 
with the help of the cellular folding machinery, generally assisting in the folding of several 
proteins. For example, the folding of the Hsp60 chaperonin was reported to rely on native 
Hsp60 complexes (Cheng et al. 1990). Moreover, the bacterial Hsp70 counterpart, DnaK, 
could be efficiently refolded in vitro (Montgomery et al. 1993; Clerico et al. 2010) and its 
folding could be assisted by the large ribosomal RNA molecules that exhibit general 
folding activities (Ghosh et al. 2003; Kim et al. 2010).  However, the present study 
describes for the first time a chaperone relying on a specialized proteinaceous factor for its 
folding. This specialized factor is Hep1 and it is crucial for the correct folding of the Ssc1 
chaperone, both in vivo and in vitro.  
A potential role of Hep1 in Ssc1 folding has previously been proposed. In addition to 
aggregation of native Ssc1, aggregated material could also be formed during the biogenesis 
of Ssc1 and a folding intermediate of Ssc1 could correspond to the aggregation-prone form 
of Ssc1. In such a case, the anti-aggregating function of Hep1 would be exhibited by its 
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assistance in the folding process of Ssc1. Previous reports support this hypothesis with 
some non-direct evidence. Sichting et al. (2005) showed that the co-expression of Ssc1 
with the chaperone Hep1 in a bacterial system is essential to produce soluble and 
functional Ssc1. Moreover, Willmund et al. (2008) found that the plastidic counterpart of 
Hep1, HEP2, similarly rescues the cognate chaperone HSP70B from the algae 
Chlamydomonas reinhardtii upon co-expression in E.coli, and provided evidence for the 
involvement of HEP2 in the activation of HSP70B upon the cleavage of the transit peptide. 
These observations might reflect the assistance of Hep proteins in the de novo folding of 
cognate Hsp70 chaperones; a different mechanism, however, could not be excluded. The 
present work for the first time unambiguously demonstrates the key role of Hep1 in the 
folding of the Ssc1 chaperone, both in vivo and in a reconstituted system. 
Using the in organello approach, as well as the reconstituted system, the key factors 
required for Ssc1 folding were identified and important mechanistic insights into this 
process were obtained.  
In the case of multidomain proteins, single domains might first fold independently and 
then cooperate to adopt the overall native conformation in the final step of folding. This 
seems to be the case for Ssc1. The ATPase domain and the PBD acquire their native 
structure independently, both in vivo and in vitro. Whereas the ATPase domain requires the 
assistance of Hep1 and the presence of the nucleotides for folding, the PBD seems to fold 
spontaneously without any additional factors. These conclusions are supported by in 
organello and in vitro results using full-length Ssc1, as well as single domain constructs.  
As shown in section 3.1.3, the interdomain linker segment is crucial for the interaction 
of Ssc1 with Hep1. Presumably, the ATPase domain of Ssc1 upon interaction with the 
linker acquires a conformation that is recognized by Hep1. At the same time, the linker 
seems to play an important role in the overall folding of the ATPase domain, since the 
DHFR fusion constructs consisting of ATPase alone or the ATPase with the mutated linker 
did not fold. Moreover, the ATPase domain in full-length Ssc1 with the mutated linker did 
not fold either. The lack of the correct interdomain linker, crucial for the interaction with 
Hep1, may hinder recognition of the folding intermediate of Ssc1 by Hep1. Therefore, 
Hep1 cannot assist in the folding process of Ssc1 and the process is stalled. It would be 
interesting to study the role of the interdomain linker for the folding of Ssc1 in the 
reconstituted system. Particularly, experiments addressing the interaction of a peptide 
resembling the linker peptide with Hep1 and the influence of this peptide added in trans on 
Discussion 
 
 91
the folding of the ATPase domain would help to understand the function of the linker for 
the folding process of Ssc1. 
Besides Hep1, an adenine nucleotide was found to be crucial for the folding of Ssc1. 
Interestingly, since both ATP and ADP can be used in the folding process, it is not the 
hydrolysis of ATP but rather the binding of nucleotide to the ATPase domain that is 
required to trigger Ssc1 folding. Moreover, the nucleotide dependent step in the folding 
pathway of Ssc1 occurs apparently after binding of Hep1 to Ssc1. What is the function of 
the nucleotide in the folding process? The nucleotide binds to the Hep1-bound folding 
intermediate of Ssc1 and seems to be crucial for stabilizing a more compact conformation 
of the ATPase domain. The binding of the nucleotide to the nucleotide-binding pocket of 
Ssc1 stabilizes the pocket, and this presumably leads to the structural stabilization of the 
entire domain. Moreover, binding of the nucleotide apparently triggers dissociation of 
Hep1. This is consistent with the observation that Ssc1 interacts with Hep1 only upon 
depletion of ATP (Sichting et al. 2005). Ssc1 seems to have a distinct preference for 
nucleotides that promote its folding. Both ATP and ADP promote the folding of Ssc1 in 
the presence of Hep1, whereas an ATP analogue, AMP-PNP, despite binding to the native 
Ssc1, does not. The affinity of AMP-PNP to the unstructured folding intermediate of Ssc1 
might be too low. It could also be that AMP-PNP does bind to the intermediate, but is not 
able to trigger release of Hep1, required for further folding of Ssc1. However, the second 
possibility is less likely, since the Ssc1-Hep1 complex is quite unstable and at least some 
of the Hep1 molecules would presumably spontaneously dissociate from Ssc1, allowing 
the formation of folded Ssc1. The third possibility is that AMP-PNP binding does not 
stabilize the ATPase domain similarly to ATP or ADP. Thus, Ssc1 is not able to acquire 
the native conformation.  
The presented results allow the drawing of an initial model of the Ssc1 folding 
pathway (Fig. 4.2). As suggested above, both domains of Ssc1 start folding independently 
and simultaneously. The PBD folds on its own and rapidly acquires a trypsin-resistant, thus 
folded conformation. The ATPase domain together with the interdomain linker forms a 
folding intermediate, presumably partially folded, yet trypsin-sensitive, that cannot 
efficiently fold further without Hep1. This intermediate probably does not represent an off-
pathway state, since Ssc1 remains folding-competent and does not aggregate upon a long 
incubation in higher temperatures in the absence of Hep1. Hep1 recognizes this folding 
intermediate and interacts with it, triggering the formation of the nucleotide binding 
pocket. This interaction is most probably transient, since the complex of Ssc1 intermediate 
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and Hep1 could not be observed without trapping it with a crosslinking reagent. In the next 
step, a nucleotide, ATP or ADP, binds to the folding intermediate and Hep1 is released 
from the complex. Binding of a nucleotide triggers further folding of the ATPase domain 
to the trypsin-resistant conformation. Finally, the folded ATPase domain and the PBD 
cooperate with each other to form the compact, native conformer of Ssc1, fully resistant 
against trypsin and catalytically active. 
 
 
 
 
Figure 4.2. Model of the folding pathway of Ssc1. 
The ATPase domain and the PBD of Ssc1 fold independently. The ATPase domain undergoes a 
Hep1-dependent and an ATP/ADP-dependent step in the folding process. The PBD domain folds 
spontaneously and, for simplicity, it is depicted in a folded state in all folding intermediates of Ssc1, 
although it presumably folds simultaneously with the ATPase domain. In the final folding step, both 
domains cooperate together to acquire the final structure of Ssc1. The presented model depicts 
additionally a transition of native Ssc1 to the aggregation-prone conformer and the anti-aggregation 
action of Hep1 presented in the previous model (see Fig. 4.1).   
 
 
In the presented model, the folding of Ssc1 begins with the completely unfolded, 
mature protein. In vivo, newly synthesized Ssc1 is imported into mitochondria in an 
unfolded state as a pre-protein containing an N-terminal signal peptide. In the 
mitochondrial matrix, the newly imported Ssc1 has to be released from the native Ssc1 
taking part in the translocation process, and the signal peptide has to be cleaved off. It is 
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not known whether those actions have been completed before Ssc1 starts folding. 
Moreover, one cannot exclude that the ATPase domain, which enters the mitochondria 
first, begins to fold while the rest of the protein is still being translocated. Definitely, in 
vivo, the folding process is very rapid, and it was not possible to separate it in time from 
the translocation process with the in organello approach. Although the situation seems to 
be more complex in vivo than in the reconstituted system, one can assume that the main 
steps on the folding pathway of Ssc1 in vivo and in vitro are similar, since all the results 
obtained in vivo, in organello and in the reconstituted system are consistent and lead to the 
same overall picture. 
Does the involvement of Hep1 in the de novo folding of Ssc1 fit to the previous 
picture of Hep1 function in the prevention of Ssc1 aggregation? The presented model 
depicts additionally the formation of an aggregation-prone conformer of Ssc1 from the 
nucleotide-free form of Ssc1 during the ATPase cycle. Since denatured Ssc1 did not 
aggregate upon dilution in the refolding buffer in the absence of Hep1, it could mean that 
only folded Ssc1 can adopt an aggregation-prone conformation during the ATPase cycle. 
On the other hand, the presence of 400 mM urea in the refolding buffer upon dilution of 
denatured Ssc1 could prevent aggregation of unfolded Ssc1. Moreover, molecular 
crowding might contribute to the potential aggregation propensity of unfolded Ssc1 in vivo. 
Therefore, the transition of native Ssc1 through the nucleotide-free form to the 
aggregation-prone conformer, and Hep1 counteraction of aggregation is depicted in the 
model separately from the folding pathway of Ssc1. Whether the aggregation-prone 
conformer of Ssc1 is similar, at least partially, to the folding intermediate of Ssc1 and 
whether the Hep1 action in aggregation prevention and in the de novo folding of Ssc1 
relies on a similar molecular mechanism, remain to be answered. In any case, the 
engagement of Hep1 in those two separate processes, protein folding and aggregation 
prevention, is a property typical of many chaperones. 
Is the function in the de novo folding of Ssc1 specific for Hep1, or do other auxiliary 
interaction partners of Ssc1 also have a stabilizing effect on Ssc1? The co-chaperone 
Mge1, which binds to the ATPase domain of Ssc1, was reported to increase the solubility 
of Ssc1 upon co-expression in E.coli, similarly to Hep1 (Momose et al. 2007). However, 
our in vitro data show that Mge1 alone is not able to promote folding of Ssc1, since it fails 
to recognize and interact with a folding intermediate of Ssc1. This implies that the 
assistance in the de novo folding of Ssc1 is the primary function of Hep1, and not a 
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stabilizing effect that could be taken over by any interaction partner binding to the ATPase 
domain. 
In organello and in vitro, Hep1 seems to be indispensable for the folding of the 
ATPase domain of Ssc1 at all temperatures tested. In vivo, however, deletion of the HEP1 
gene is lethal for yeast cells only at elevated temperatures and it seems to have a minor 
effect on the activity of Ssc1 at lower temperature. Therefore, it is likely that there is an 
additional folding helper for Ssc1 in vivo. In the mitochondrial matrix, several chaperone 
systems involved in protein folding and dissaggregation have been described, including the 
Hsp60 chaperonin machinery, the mtHsp70 chaperone system as well as a member of the 
Clp/Hsp100 family, the Hsp78 chaperone (Voos 2009). Those three systems were tested 
for the involvement in the de novo folding of Ssc1 in organello and no significant effects 
of the mutation/deletion of those chaperone systems on the folding of Ssc1 were observed 
in the presence of Hep1. It is probable, however, that one of the aforementioned systems 
or/and an additional factor, yet to be identified, assists in the Ssc1 folding in the absence of 
Hep1 in vivo, and in the presence of Hep1 it plays only a minor role. One cannot exclude 
that a pool of newly imported Ssc1 is able to fold spontaneously. Nevertheless, due to the 
effect of strong molecular crowding in vivo, it is more likely that Ssc1, as a rather large, 
two-domain protein is assisted in folding by additional factors, which are working 
efficiently in the absence of Hep1 at lower temperatures, but are not sufficient in 
organello. 
Interestingly, Hep1 homologues were identified only in mitochondria and chloroplasts 
of eukaryotes, and no Hep-related proteins were found in bacteria (Sichting et al. 2005; 
Willmund et al. 2008). Despite some evidence for additional functions of Hep1 
homologues (Burri et al. 2004; Zhai et al. 2008; Goswami et al. 2010), this study shows 
that the assistance in the de novo folding of the cognate Hsp70 chaperones is the primary 
and major function of Hep proteins. This suggests that the folding pathway of 
mitochondrial and plastidic Hsp70 chaperones is more complex and their free-energy 
folding landscapes are much more rugged than those of the other Hsp70 family members. 
Thus, they may require the specialized folding helpers to overcome the energetic barriers 
and to rapidly reach the native state. Why do the folding pathways of mitochondrial and 
plastidic Hsp70 chaperones differ from the other ones? As discussed before, those 
chaperones, due to their involvement in the complicated processes of protein translocation 
in parallel to protein folding-related functions, need to acquire highly flexible and dynamic 
structures. Reaching these structures during de novo folding of those chaperones may thus 
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lead to the formation of kinetically trapped intermediates and only binding of the Hep-
related protein catalyzes further folding into the final conformation. On the other hand, 
Hep dependence might be a cellular way to prevent non-physiological folding of the 
chaperone in the cytosol, before it is translocated into the target organelle. 
The present study focused on the biogenesis of the yeast mitochondrial Hsp70 Ssc1 
and the function of yeast Hep1. The human Hep1 homologue, HEP, called also DNLZ, was 
shown to interact with the ATPase domain in combination with the interdomain linker of 
the human mtHsp70, mortalin, and to increase the solubility of mortalin upon co-
expression in bacteria, similarly to the yeast counterparts (Zhai et al. 2008). In contrast to 
Hep1, however, several studies demonstrated that human HEP stimulates the ATPase 
activity of mortalin (Zhai et al. 2008; Goswami et al. 2010; Zhai et al. 2011; Vu et al. 
2012). Moreover, HEP was shown to have an anti-aggregation effect on the model 
substrate rhodanese in vitro (Goswami et al. 2010). Since the human HEP could partially 
complement the deletion of Hep1 in yeast (Vu et al. 2012), one could expect that its 
primary function is conserved. It would be, therefore, interesting to study the role of 
human HEP for the de novo folding of mortalin as well as to investigate in detail the new 
functions that the human HEP seemed to have acquired during the evolution. Furthermore, 
accumulating evidence points towards the involvement of mortalin in the regulation of 
cellular senescence and immortalization. This links mortalin to carcinogenesis and aging 
processes. Mortalin was shown to be highly upregulated in many tumor tissues including 
breast, brain and colon carcinoma and has already been suggested to be a biomarker for the 
prediction of recurrence in hepatocellular carcinoma (Wadhwa et al. 2006; Yi et al. 2008; 
Chen et al. 2011). Moreover, it was reported to be involved in the pathogenesis of 
Parkinson’s disease (Burbulla et al. 2010). Multiple functions of mortalin and their 
complicated regulation make the human mtHsp70 system more complex than the yeast 
one. It would be, therefore, highly exciting to study the biogenesis of mortalin, using the 
well-defined tools developed for the study of the yeast Ssc1 chaperone. 
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5. Summary 
Molecular chaperones of the Hsp70 class are essential for a number of cellular 
processes. The yeast mitochondrial Hsp70 chaperone Ssc1 plays an indispensable role for 
the mitochondrial biogenesis. As an essential component of the import motor of the TIM23 
transolcase, Ssc1 drives the ATP-dependent translocation of proteins into the 
mitochondrial matrix. Moreover, it mediates the de novo folding and the assembly of 
several proteins in the mitochondrial matrix and prevents the formation of protein 
aggregates. Surprisingly, Ssc1 itself has a propensity to self-aggregate. Thus, it requires a 
helper protein, the chaperone Hep1 that prevents Ssc1 aggregation and maintains its 
structure and function. The mechanism of the protective function of Hep1 on Ssc1, 
however, is not understood. 
In the present study, the structural determinants of Ssc1 that make it prone to 
aggregation and the structural requirements of Ssc1 for its interaction with Hep1 were 
analysed and provided insights into the mechanism of prevention of Ssc1 aggregation by 
Hep1. The aggregation studies demonstrate that a variant of Ssc1 consisting of the ATPase 
domain and the subsequent interdomain linker aggregates in absence of Hep1. In contrast, 
the PBD and the ATPase domain alone are not prone to aggregation. Moreover, the 
interaction studies reveal that the aggregation-prone region seems to be the smallest entity 
within Ssc1 required for the interaction with Hep1. Taken together, the native Ssc1 adopts 
an aggregation-prone conformation, in which the ATPase domain with the interdomain 
linker has the propensity to aggregate. Hep1 binds to this aggregation-prone region and 
thereby counteracts the aggregation process and keeps the native Ssc1 in a functional and 
active state. 
Although Hsp70 chaperones are important for the biogenesis of a multitude of 
proteins, little is known about the biogenesis of these chaperones themselves. The present 
study reports on the analysis of the folding process of the mitochondrial Hsp70 chaperone 
Ssc1. In organello, in vivo and in vitro assays were established and then employed to study 
the de novo folding of Ssc1. Upon import into mitochondria, Ssc1 folds rapidly with the 
ATPase domain and the PBD adopting their structures independently of each other. 
Notably, the ATPase domain requires the presence of the interdomain linker for its folding, 
whereas the PBD folds without the linker. Moreover, in the absence of Hep1, the ATPase 
domain with the interdomain linker displays a severe folding defect, which indicates a role 
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of Hep1 in the folding process of Ssc1. Apart from Hep1, none of the general 
mitochondrial chaperone systems seem to be important for the folding of Ssc1. 
Furthermore, the folding process of Ssc1 was reconstituted in vitro and the main steps of 
the folding pathway of Ssc1 were characterised. Hep1 and ATP/ADP are required and 
sufficient for the folding of Ssc1 into the native, catalytically active form. In an early step 
of folding, Hep1 interacts with the folding intermediate of Ssc1. This interaction induces 
conformational changes which allow binding of ATP/ADP. The binding of a nucleotide 
triggers Hep1 release and further folding of the intermediate into a native Ssc1.  
The present study provides the first direct evidence for the requirement of Hep1 for 
the folding of the Ssc1 chaperone. Thus, it demonstrates for the first time that the de novo 
folding of an Hsp70 chaperone depends on a specialized proteinaceous factor. 
In conclusion, Hep1 fulfils a dual chaperone function in the cell. It mediates the de 
novo folding of Ssc1 and maintains folded Ssc1 in a functional state during the ATPase 
cycle. Therefore, the Hep1 chaperone plays a crucial role for the protein biogenesis and 
homeostasis in mitochondria.  
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7. Abbreviations 
AAA 
ADP 
Amp 
AMP-PNP 
APS 
Arg 
Asp 
ATP 
ATPase 
ATPS 
BSA 
C-terminus 
CCT 
cDNA 
CNBr 
CTP 
cyt 
DHFR 
DMSO 
DNA 
dNTP 
DSG 
DTT 
E. coli 
EDTA 
ER 
FT 
g 
GTP 
h 
HCl 
HEPES 
His 
His-tag 
HRP 
Hsc 
Hsp 
ATPase Associated with various cellular Activities 
adenosine diphosphate 
ampicillin 
adenylyl imidodiphosphate 
ammonium persulfate 
arginine 
aspartic acid 
adenosine triphosphate 
adenosine triphosphatase 
Adenosine-5'-(γ-thio)-triphosphate 
Bovine Serum Albumin 
carboxy-terminus 
chaperonin containing TCP-1 
complementary DNA 
cyanogen bromide 
cytidine triphosphate 
cytochrome 
dihydrofolate reductase 
dimethylsulfoxid 
deoxyribonucleic acid 
deoxyribonucleoside triphosphate 
disuccinimidyl glutarate 
dithiotreitol 
Escherichia coli 
ethylendiamine tetraacetate 
endoplasmic reticulum 
flow-through 
acceleration of gravity 
guanosine triphosphate 
hour 
hydrochloric acid 
N-2 hydroxyl piperazine-N´-2-ethane sulphonic acid 
histidine 
hexahistidine tag 
horseradish peroxidase 
heat shock cognate 
heat shock protein 
Abbreviations 
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IgG 
IM 
IMS 
IP 
IPTG 
kb 
kDa 
kV 
LB 
MDa 
Mdj 
Mia 
MOPS 
mRNA 
mt 
MTS 
N-terminus 
NAC 
NADH 
NEF 
NiNTA 
NMR 
OD600 
OM 
O/N 
ORF 
PAGE 
PBD 
PCR 
PEG 
PI 
PK 
PMSF 
RAC 
RNA 
RNasin 
rpm 
RT 
S. cerevisiae 
SAM 
SD 
SDS 
immunoglobulin G 
inner membrane 
intermembrane space 
immunoprecipitation 
isopropyl-β,D-thiogalactopyranoside 
kilobase 
kiloDalton 
kilovolt 
Luria Bertani 
megaDalton 
mitochondrial DnaJ 
Mitochondrial intermembrane space Import and Assembly 
N-morpholinopropane sulphonic acid 
messenger ribonucleic acid 
mitochondrial 
matrix targeting signal 
amino-terminus 
Nascent chain-Associated Complex 
nicotine amide adenine dinucleotide 
nucleotide exchange factor 
nickel-nitrilo triacetic acid 
nuclear magnetic resonance 
optical density at 600 nm 
outer membrane 
overnight 
open reading frame 
polyacrylamide gel electrophoresis 
peptide binding domain 
polymerase chain reaction 
polyethylene glycol 
pre-immune serum 
proteinase K 
phenylmethylsulfonyl fluoride 
Ribosome-Associated Complex 
ribonucleic acid 
ribonuclease inhibitor 
rounds per minute 
room temperature 
Saccharomyces cerevisiae 
Sorting and Assembly Machinery 
selective dextrose 
sodium dodecyl sulfate 
Abbreviations 
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SH 
SOC 
STI 
Su9 
TAE 
TBS 
TCA 
TEMED 
TIM 
TOB 
TOM 
TRiC 
TRIS 
U 
UTP 
UV 
v/v 
w/v 
WT 
YPD 
YPG 
YPGal 

 
sorbitol, HEPES 
Super Optimal broth with Catabolite repression 
soybean trypsin inhibitor 
subunit 9 
TRIS, acetic acid, EDTA 
TRIS buffered saline 
trichloroacetic acid 
N,N,N‘,N‘-tetramethylene diamine 
translocase of inner mitochondrial membrane 
Topogenesis of mitochondrial Outer-membrane β-Barrel proteins 
translocase of outer mitochondrial membrane 
TCP-1 Ring Complex 
tris-(hydroxymethyl)-aminomethane 
unit 
uridine triphosphate 
ultraviolet 
volume per volume 
weight per volume 
wild-type 
yeast extract, peptone, dextrose 
yeast extract, peptone, glycerol 
yeast extract, peptone, galactose 
membrane potential 
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